<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">79433</article-id><article-id pub-id-type="doi">10.7554/eLife.79433</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Phorbolester-activated Munc13-1 and ubMunc13-2 exert opposing effects on dense-core vesicle secretion</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-276939"><name><surname>Houy</surname><given-names>Sébastien</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-213990"><name><surname>Martins</surname><given-names>Joana S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6721-2935</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-284738"><name><surname>Lipstein</surname><given-names>Noa</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0755-5899</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-5632"><name><surname>Sørensen</surname><given-names>Jakob Balslev</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5465-3769</contrib-id><email>jakobbs@sund.ku.dk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/035b05819</institution-id><institution>Department of Neuroscience, University of Copenhagen</institution></institution-wrap><addr-line><named-content content-type="city">Copenhagen</named-content></addr-line><country>Denmark</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03av75f26</institution-id><institution>Department of Molecular Neurobiology, Max-Planck-Institute for Multidisciplinary Sciences</institution></institution-wrap><addr-line><named-content content-type="city">Göttingen</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/010s54n03</institution-id><institution>Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)</institution></institution-wrap><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Brunger</surname><given-names>Axel T</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/006w34k90</institution-id><institution>Stanford University School of Medicine, Howard Hughes Medical Institute</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Pfeffer</surname><given-names>Suzanne R</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Stanford University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>10</day><month>10</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e79433</elocation-id><history><date date-type="received" iso-8601-date="2022-04-12"><day>12</day><month>04</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-10-06"><day>06</day><month>10</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-04-29"><day>29</day><month>04</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.04.27.489716"/></event></pub-history><permissions><copyright-statement>© 2022, Houy, Martins et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Houy, Martins et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-79433-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-79433-figures-v2.pdf"/><abstract><p>Munc13 proteins are priming factors for SNARE-dependent exocytosis, which are activated by diacylglycerol (DAG)-binding to their C1-domain. Several Munc13 paralogs exist, but their differential roles are not well understood. We studied the interdependence of phorbolesters (DAG mimics) with Munc13-1 and ubMunc13-2 in mouse adrenal chromaffin cells. Although expression of either Munc13-1 or ubMunc13-2 stimulated secretion, phorbolester was only stimulatory for secretion when ubMunc13-2 expression dominated, but inhibitory when Munc13-1 dominated. Accordingly, phorbolester stimulated secretion in wildtype cells, or cells overexpressing ubMunc13-2, but inhibited secretion in Munc13-2/<italic>Unc13b</italic> knockout (KO) cells or in cells overexpressing Munc13-1. Phorbolester was more stimulatory in the Munc13-1/<italic>Unc13a</italic> KO than in WT littermates, showing that endogenous Munc13-1 limits the effects of phorbolester. Imaging showed that ubMunc13-2 traffics to the plasma membrane with a time-course matching Ca<sup>2+</sup>-dependent secretion, and trafficking is independent of Synaptotagmin-7 (Syt7). However, in the absence of Syt7, phorbolester became inhibitory for both Munc13-1 and ubMunc13-2-driven secretion, indicating that stimulatory phorbolester x Munc13-2 interaction depends on functional pairing with Syt7. Overall, DAG/phorbolester, ubMunc13-2 and Syt7 form a stimulatory triad for dense-core vesicle priming.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>neurotransmitter release</kwd><kwd>capacitance measurements</kwd><kwd>exocytosis</kwd><kwd>vesicle priming</kwd><kwd>vesicle fusion</kwd><kwd>adrenal chromaffin cell</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009708</institution-id><institution>Novo Nordisk Fonden</institution></institution-wrap></funding-source><award-id>NNF19OC0058298</award-id><principal-award-recipient><name><surname>Sørensen</surname><given-names>Jakob Balslev</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004836</institution-id><institution>Independent Research Fund Denmark</institution></institution-wrap></funding-source><award-id>0134-00141A</award-id><principal-award-recipient><name><surname>Sørensen</surname><given-names>Jakob Balslev</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003554</institution-id><institution>Lundbeckfonden</institution></institution-wrap></funding-source><award-id>R277-2018-802</award-id><principal-award-recipient><name><surname>Sørensen</surname><given-names>Jakob Balslev</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>EXC-2049 - 390688087</award-id><principal-award-recipient><name><surname>Lipstein</surname><given-names>Noa</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SFB1286/A11</award-id><principal-award-recipient><name><surname>Lipstein</surname><given-names>Noa</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The priming protein ubMunc13-2 and Synaptotagmin-7 cooperate with phorbolesters/diacylglycerol to stimulate vesicle priming in adrenal chromaffin cells, whereas phorbolesters/diacylglycerol interacting with Munc13-1 inhibit vesicle fusion, which identifies opposing functions of these two Munc13 proteins.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Release of chemical neurotransmitters by exocytosis of small synaptic vesicles (SV) forms the basis for rapid communication between neurons, whereas larger dense core vesicles (DV) contain neuropeptides necessary for neuromodulation. The machinery for exocytosis of SVs and DVs must incorporate both a basic lipid fusion apparatus, and layers of control that enable vesicular release to be restricted in time and space. The SNARE-complex, formed between vesicular VAMP/synaptobrevin, and plasma membrane located syntaxin-1 and SNAP-25, is the canonical fusion machinery (<xref ref-type="bibr" rid="bib72">Rizo, 2018</xref>), and its mutation leads to complex neurodevelopmental disorders (<xref ref-type="bibr" rid="bib92">Verhage and Sørensen, 2020</xref>). SNARE-complex formation is widely believed to coincide with vesicle priming, the process that renders the vesicle releasable (<xref ref-type="bibr" rid="bib84">Sørensen et al., 2006</xref>). Upstream processes regulating SNARE-complex formation therefore become priming factors <italic>par excellence</italic>; this includes Munc18-1 and Munc13 proteins. Munc18-1 binds to an inactivated, ‘closed’ syntaxin-1 configuration (<xref ref-type="bibr" rid="bib21">Dulubova et al., 1999</xref>). Munc13s facilitate the opening of syntaxin-1 through their catalytic MUN-domain (<xref ref-type="bibr" rid="bib51">Ma et al., 2011</xref>; <xref ref-type="bibr" rid="bib71">Richmond et al., 2001</xref>; <xref ref-type="bibr" rid="bib97">Yang et al., 2015</xref>), which allows Munc18-1 to act as a template for SNARE-complex formation (<xref ref-type="bibr" rid="bib9">Baker et al., 2015</xref>; <xref ref-type="bibr" rid="bib36">Kalyana Sundaram et al., 2021</xref>; <xref ref-type="bibr" rid="bib66">Parisotto et al., 2014</xref>; <xref ref-type="bibr" rid="bib79">Shu et al., 2020</xref>; <xref ref-type="bibr" rid="bib80">Sitarska et al., 2017</xref>). Synaptotagmin-1 binds to Ca<sup>2+</sup> and triggers release in an interplay with complexin and the SNAREs themselves (<xref ref-type="bibr" rid="bib58">Mohrmann et al., 2015</xref>; <xref ref-type="bibr" rid="bib87">Südhof, 2013</xref>). Synaptotagmin-7 (Syt7) is a slower Ca<sup>2+</sup>-sensor, which is able to both trigger slow release downstream of SNARE-complex formation (<xref ref-type="bibr" rid="bib8">Bacaj et al., 2013</xref>; <xref ref-type="bibr" rid="bib75">Schonn et al., 2008</xref>), but also to act upstream of complex formation in a role leading to Ca<sup>2+</sup>-dependent vesicle priming (<xref ref-type="bibr" rid="bib48">Liu et al., 2014</xref>; <xref ref-type="bibr" rid="bib88">Tawfik et al., 2021</xref>). The exocytotic cascade culminates in the formation of a fusion pore through which water-soluble signaling molecules can escape (<xref ref-type="bibr" rid="bib1">Álvarez de Toledo et al., 2018</xref>; <xref ref-type="bibr" rid="bib17">Chang et al., 2017</xref>; <xref ref-type="bibr" rid="bib77">Sharma and Lindau, 2018</xref>).</p><p>The vesicle priming machinery incorporates several points of regulation, triggered by receptor activation, or intracellular Ca<sup>2+</sup>. One of them is the binding of DAG to the C1-domain in Munc13 proteins (<xref ref-type="bibr" rid="bib11">Betz et al., 1998</xref>), often studied using β-phorbolesters, which are DAG-mimics that potentiate release from chromaffin cells (<xref ref-type="bibr" rid="bib81">Smith et al., 1998</xref>) and central synapses (<xref ref-type="bibr" rid="bib50">Lou et al., 2005</xref>; <xref ref-type="bibr" rid="bib52">Malenka et al., 1986</xref>; <xref ref-type="bibr" rid="bib76">Shapira et al., 1987</xref>). Phorbolester targets Munc13s to the plasma membrane (<xref ref-type="bibr" rid="bib5">Ashery et al., 2000</xref>; <xref ref-type="bibr" rid="bib11">Betz et al., 1998</xref>). Upon mutation to unfold the C1-domain of Munc13-1 (H567K), phorbolester does not potentiate glutamatergic neurotransmission in cultured hippocampal neurons (<xref ref-type="bibr" rid="bib70">Rhee et al., 2002</xref>). Later experiments showed that both the C1-domain and the Ca<sup>2+</sup>-unbound C2B-domain are inhibitory (<xref ref-type="bibr" rid="bib43">Li et al., 2019</xref>; <xref ref-type="bibr" rid="bib56">Michelassi et al., 2017</xref>), but inhibition can be relieved by Ca<sup>2+</sup>-binding to the C2B-domain, or binding of DAG to C1 (<xref ref-type="bibr" rid="bib56">Michelassi et al., 2017</xref>). Structural studies have identified a ~20 nm elongated rod-like structure formed by the C1-C2B-MUN domain (<xref ref-type="bibr" rid="bib96">Xu et al., 2017</xref>). The C-terminal C2C-domain on the other side of this rod binds to membranes, but not to Ca<sup>2+</sup>. This makes it possible for the C1-C2B-MUN-C2C structure to bridge the plasma and vesicular membranes, which is necessary for neurotransmitter release (<xref ref-type="bibr" rid="bib49">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="bib65">Padmanarayana et al., 2021</xref>; <xref ref-type="bibr" rid="bib69">Quade et al., 2019</xref>). Bridging can take place at different angles, depending on the binding mode at the plasma membrane; one binding mode uses a polybasic face and results in an upright/perpendicular orientation that hinders release, whereas another binding mode involves DAG-Ca<sup>2+</sup>-PIP<sub>2</sub>-binding by the C1-C2B-domain, which results in a slanted orientation that facilitates release (<xref ref-type="bibr" rid="bib16">Camacho et al., 2021</xref>). Ca<sup>2+</sup>/phospholipid-binding to the C2B-domain accelerates SV recruitment and reduces synaptic depression (<xref ref-type="bibr" rid="bib46">Lipstein et al., 2021</xref>). Similar effects are seen upon calmodulin (CaM)-binding, with different penetrance in different synapses (<xref ref-type="bibr" rid="bib33">Junge et al., 2004</xref>; <xref ref-type="bibr" rid="bib45">Lipstein et al., 2013</xref>).</p><p>Munc13 proteins exist as different paralogs with overlapping functions. Munc13-1 is critically involved in synaptic vesicle release, with glutamate release arrested in most synapses in the absence of Munc13-1 (<xref ref-type="bibr" rid="bib7">Augustin et al., 1999b</xref>). Munc13-2 exists as two different isoforms, due to alternative promotors; ubMunc13-2 is ubiquitously expressed, whereas bMunc13-2 is brain specific (<xref ref-type="bibr" rid="bib14">Brose et al., 1995</xref>; <xref ref-type="bibr" rid="bib38">Kawabe et al., 2017</xref>). Recently, mutations in Munc13-2 were linked to human epilepsy (<xref ref-type="bibr" rid="bib93">Wang et al., 2021a</xref>). bMunc13-2 is expressed in a subset of glutamatergic synapses (<xref ref-type="bibr" rid="bib38">Kawabe et al., 2017</xref>), and shapes paired pulse ratio and frequency facilitation at the hippocampal mossy fiber synapse (<xref ref-type="bibr" rid="bib13">Breustedt et al., 2010</xref>). In synapses formed by pyramidal cells on GABAergic interneurons in the CA1 region of the hippocampus both Munc13-1 and Munc13-2 are expressed, but no consequences were identified upon Munc13-2 deletion (<xref ref-type="bibr" rid="bib27">Holderith et al., 2021</xref>). Similarly, Munc13-2 deletion was without consequence in the Calyx of Held synapse (<xref ref-type="bibr" rid="bib18">Chen et al., 2013</xref>) or the mouse photoreceptor ribbon synapse (<xref ref-type="bibr" rid="bib19">Cooper et al., 2012</xref>). Munc13-1 is also involved in insulin secretion (<xref ref-type="bibr" rid="bib37">Kang et al., 2006</xref>; <xref ref-type="bibr" rid="bib42">Kwan et al., 2006</xref>; <xref ref-type="bibr" rid="bib78">Sheu et al., 2003</xref>). In neurons, elimination of both Munc13-2 and Munc13-1 reduced the release of DVs by approximately 60%, whereas overexpression of Munc13-1 specifically increased DV secretion at extrasynaptic sites (<xref ref-type="bibr" rid="bib89">van de Bospoort et al., 2012</xref>). ubMunc13-2 is involved in release of adrenaline/noradrenaline from adrenal chromaffin cells, as its hyper- and hypo-expression causes correlated changes in release (<xref ref-type="bibr" rid="bib53">Man et al., 2015</xref>). Adrenal chromaffin cells also express Munc13-1, but no consequences were identified upon its deletion (<xref ref-type="bibr" rid="bib53">Man et al., 2015</xref>). In an in vitro fusion assay, the C1-C2-MUN domain of Munc13-1 strongly stimulated fusion of synaptic vesicles, sped up fusion of insulin granules, but had no effect on DVs from PC12-cells (<xref ref-type="bibr" rid="bib39">Kreutzberger et al., 2017</xref>; <xref ref-type="bibr" rid="bib40">Kreutzberger et al., 2019</xref>).</p><p>Here, we set out to understand the different roles of Munc13-1 and ubMunc13-2 co-expressed in adrenal chromaffin cells (<xref ref-type="bibr" rid="bib53">Man et al., 2015</xref>). Munc13-1 and ubMunc13-2 both contain DAG/phorbolester-binding C1-domains. We surprisingly find that phorbolester can be positive or negative for DV secretion depending on the expressed Munc13 paralog. The stimulatory effect of phorbolester on DV fusion depends on the co-expression of ubMunc13-2 and Syt7 in the same cell, identifying a stimulatory triad of ubMunc13-2, Syt7 and DAG/phorbolester for DV priming.</p></sec><sec id="s2" sec-type="results"><title>Results</title><p>Mouse adrenal chromaffin cells have proven useful for deciphering the molecular basis of neurotransmitter release (<xref ref-type="bibr" rid="bib61">Neher, 2018</xref>). Being small and compact, they are ideal for patch-clamp capacitance measurements, and release can be stimulated rapidly by Ca<sup>2+</sup>-uncaging (<xref ref-type="bibr" rid="bib29">Houy et al., 2021</xref>), which bypasses Ca<sup>2+</sup>-influx, allowing a focus on the release machinery. Ca<sup>2+</sup>-uncaging empties the primed vesicle pools and allows simultaneous determination of vesicle pool sizes and fusion rates. Mouse adrenal chromaffin cells express both Munc13-1 and ubMunc13-2, encoded by the genes <italic>Unc13a</italic> and <italic>Unc13b</italic>, respectively. Previous work showed that Munc13-1 overexpression in bovine chromaffin cells (<xref ref-type="bibr" rid="bib5">Ashery et al., 2000</xref>; <xref ref-type="bibr" rid="bib12">Betz et al., 2001</xref>), in mouse WT cells (<xref ref-type="bibr" rid="bib86">Stevens et al., 2005</xref>) or <italic>Unc13a/Unc13b</italic> double knockout (KO) chromaffin cells (<xref ref-type="bibr" rid="bib53">Man et al., 2015</xref>) increased secretion, but ubMunc13-2 appeared even more potent (<xref ref-type="bibr" rid="bib53">Man et al., 2015</xref>). Genetic deletion of Munc13-2 in mouse chromaffin cells markedly reduced secretion, whereas no effect was detected after deletion of Munc13-1 (<xref ref-type="bibr" rid="bib53">Man et al., 2015</xref>). These findings support the notion that Munc13-1 and ubMunc13-2 play overlapping roles, with ubMunc13-2 dominating in wildtype cells, but the effect of phorbolester was not investigated.</p><sec id="s2-1"><title>Munc13-2 is required for the stimulatory effect of phorbolesters in chromaffin cells</title><p>To understand the molecular requirements for the well-known ability of phorbolester to stimulate secretion in chromaffin cells (<xref ref-type="bibr" rid="bib60">Nagy et al., 2006</xref>; <xref ref-type="bibr" rid="bib81">Smith et al., 1998</xref>), we applied Phorbol 12-Myristate 13-Acetate (PMA, 0.1 µM, applied for 5–60 min) to chromaffin cells isolated from newborn mouse <italic>Unc13b</italic> KO and WT littermates (<xref ref-type="bibr" rid="bib90">Varoqueaux et al., 2002</xref>). We stimulated secretion by calcium uncaging, and monitored exocytosis by parallel capacitance and amperometric measurements. As expected, application of PMA doubled the secretion amplitude in <italic>Unc13b</italic> WT cells, whether measured by capacitance or amperometry (<xref ref-type="fig" rid="fig1">Figure 1A</xref>; traces are the mean of all measured cells). The pre-stimulation calcium concentration was ~0.9 µM, which is near the optimal concentration for calcium-dependent vesicle priming in these cells (<xref ref-type="bibr" rid="bib68">Pinheiro et al., 2013</xref>; <xref ref-type="bibr" rid="bib88">Tawfik et al., 2021</xref>). We performed kinetic analysis of the capacitance traces by fitting them with a sum of two exponential functions and a straight line, using an automatic fitting routine (<xref ref-type="bibr" rid="bib88">Tawfik et al., 2021</xref>). This resulted in the determination of the two primed vesicle pools, which are denoted the Readily Releasable Pool (RRP), and the Slowly Releasable Pool (SRP). Both pools were increased significantly in size by PMA treatment (<italic>Unc13b</italic> WT, RRP = 88.1 fF±19.5 fF (mean ± SEM),+PMA, RRP = 232.2 fF±35.9 fF, Mann-Whitney test: <italic>P</italic>=0.0001, <italic>Unc13b</italic> WT, SRP = 48.1 fF±7.8 fF,+PMA, SRP = 110.4 fF±15.9 fF, Mann-Whitney test: p=0.0009; <xref ref-type="fig" rid="fig1">Figure 1B and E</xref>). The sustained phase of release was not significantly changed by PMA (<italic>Unc13b</italic> WT, sustained = 123.6 fF±19.8 fF,+PMA, sustained = 187.4 fF±31.3 fF, Mann-Whitney test: p=0.1641, <xref ref-type="fig" rid="fig1">Figure 1D</xref>). The kinetics of RRP release was slightly slower in the presence of PMA (<italic>Unc13b</italic> WT, τ<sub>fast</sub> = 23.0 ms,+PMA, τ<sub>fast</sub> = 30.3 ms, Mann-Whitney test: p=0.0265; <xref ref-type="fig" rid="fig1">Figure 1C</xref>), whereas the kinetics of SRP release was unchanged (<xref ref-type="fig" rid="fig1">Figure 1F</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>In the absence of Munc13-2, phorbolesters are inhibitory for dense-core vesicle secretion.</title><p>(<bold>A</bold>) Calcium uncaging experiment in <italic>Unc13b</italic> WT chromaffin cells from newborn mice (P0–P2) in the absence and presence of PMA (Black and purple traces). Top panel: [Ca<sup>2+</sup>] before (insert) and after calcium uncaging (uncaging flash at red arrow, bottom panel). Middle panel: capacitance traces (mean of all cells) show that PMA treatment potentiates secretion in WT cells (higher amplitude). Bottom panel: Mean amperometry (left ordinate axis) and mean integrated amperometry (right ordinate axis). (<bold>B</bold>) Sizes of the RRP. (<bold>C</bold>) Time constants of fusion for fast (i.e. RRP) secretion. (<bold>D</bold>) Sustained secretion (secretion during the last 4 s of the trace in <bold>A</bold>). (<bold>E</bold>) Sizes of the SRP. (<bold>F</bold>) Time constants of fusion for slow (i.e. SRP) secretion. (<bold>G</bold>) Calcium uncaging experiment in <italic>Unc13b</italic> KO in the absence and presence of PMA (red and orange traces). Panels are arranged as in A. (<bold>H</bold>) Sizes of the RRP. (<bold>I</bold>) Time constants of fusion for fast secretion. (<bold>J</bold>) Sustained secretion (secretion during the last 4 s of the trace in G). (<bold>K</bold>) Sizes of the SRP. (<bold>L</bold>) Time constants of fusion for slow secretion. Data information: In panel A and G (top) data are presented as mean ± SEM; in A and G (middle and bottom panels), the traces are the mean of all cells. In B-F and H-L, data are presented as box and whiskers. *: p&lt;0.05; **: p&lt;0.01; ***: p&lt;0.001. Mann-Whitney test comparing WT cells with WT cells treated with PMA, or KO cells with KO cells treated with PMA or. Number of cells, KO: n=21 cells; KO +PMA: n=19 cells; WT: n=24 cells; WT +PMA: n=20 cells. (<bold>M</bold>) Single confocal slices of <italic>Unc13b</italic> KO and WT mouse chromaffin cells with or without PMA stained against tyrosine hydroxylase (α-TH) and Chromogranin A (α-CgA). Scale bar: 5 µm. (<bold>N</bold>) normalized total cellular CgA fluorescence (integrated density) in Unc13b KO and WT cells with or without PMA. Kruskal-Wallis test with Dunn’s post-hoc test: no differences were significant. (<bold>O</bold>) Quantification of the plasma membrane fluorescence intensity of CgA (total divided by inside fluorescence, using integrated density) in Unc13b KO and WT cells with or without PMA (normalization to Unc13b WT). Data information: quantitative data are presented as box and whiskers. In (<bold>M–O</bold>) number of cells, KO: n=30 cells; KO +PMA: n=32 cells; WT: n=29 cells; WT +PMA: n=28 cells.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Quantitative data.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-79433-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79433-fig1-v2.tif"/></fig><p>Strikingly, when we applied PMA to cultures of chromaffin cells prepared from <italic>Unc13b</italic> KO littermates, the effect of PMA was strongly inhibitory (<xref ref-type="fig" rid="fig1">Figure 1G</xref>), leading to a factor ~3 reduction in overall release. Kinetic analysis revealed significant reductions in RRP, SRP and sustained components (<italic>Unc13b</italic> KO, RRP = 47.9 fF±14.4 fF,+PMA, RRP = 13.6 fF±5.1 fF, Mann-Whitney test: p=0.0405, <italic>Unc13b</italic> KO, SRP = 56.0 fF±10.5 fF,+PMA, SRP = 16.5 fF±3.7 fF, Mann-Whitney test: p=0.0016, <italic>Unc13b</italic> KO, sustained = 26.2 fF±7.0 fF,+PMA, sustained = 14.4 fF±4.4 fF, Mann-Whitney test: p = 0.0496 <xref ref-type="fig" rid="fig1">Figure 1H, K and J</xref>). The kinetics of RRP and SRP secretion remained unchanged (<xref ref-type="fig" rid="fig1">Figure 1I and L</xref>). Importantly, to protect against variance between cultures, measurements with and without PMA were obtained from the same cultures originating from single animals and measured on the same days. Opposite effects of PMA on <italic>Unc13b</italic> WT and KO were detected using the same batches of PMA.</p><p>Lack of secretion upon Ca<sup>2+</sup>-uncaging could be expected if PMA-treatment of <italic>Unc13b</italic> KO cells led to spontaneous release, depleting the cells of secretory vesicles. To rule out this possibility, we stained <italic>Unc13b</italic> WT and KO adrenal chromaffin cells against Tyrosine Hydroxylase (TH, a marker of adrenal chromaffin cells) and chromogranin A, a releasable component of DVs. All four groups (<italic>Unc13b</italic> WT, <italic>Unc13b</italic> WT +PMA, <italic>Unc13b</italic> KO, <italic>Unc13b</italic> KO +PMA) displayed strong chromogranin staining (<xref ref-type="fig" rid="fig1">Figure 1M–N</xref>), with a tendency towards lower staining in the WT +PMA group (p=0.1084), that is the group with the highest secretion (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Quantifying the amount of CgA staining close to the membrane also did not result in significant differences (<xref ref-type="fig" rid="fig1">Figure 1O</xref>). Thus, Unc13b KO cells have intact secretory potential with and without PMA.</p><p>These data show that in mouse adrenal chromaffin cells, ubMunc13-2 is required for phorbolester to stimulate secretion, and in its absence, phorbolester is inhibitory. Phorbolesters also activate Protein kinase C (PKC), which stimulates secretion, but apparently this effect does not prevail in the absence of ubMunc13-2, probably due to an overall weak PKC-dependence of secretion from newborn or embryonic mouse chromaffin cells (see Discussion).</p></sec><sec id="s2-2"><title>Phorbolesters are more potent in the absence of Munc13-1</title><p>We next investigated the consequence of deleting Munc13-1 for the effect of PMA. To this end, we performed measurements in <italic>Unc13a</italic> WT and KO littermate cultures. Strikingly, PMA stimulation of <italic>Unc13a</italic> KO cells led to a higher overall secretion level than in <italic>Unc13a</italic> WT cells treated with PMA (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, traces are mean of all measured cells). Kinetic analysis showed that PMA stimulated the RRP size in both <italic>Unc13a</italic> WT and Unc13a KO (<italic>Unc13a</italic> WT, RRP = 36.9 fF±7.0 fF,+PMA, RRP = 88.5 fF±11.9 fF, <italic>Unc13a</italic> KO, RRP = 44.4 fF±7.7 fF,+PMA, RRP = 169.2 fF±37.9 fF, Kruskal-Wallis test – Dunn’s multiple comparisons test WT vs WT PMA p=0.0091; KO vs KO PMA p=0.0288, <xref ref-type="fig" rid="fig2">Figure 2B</xref>). On average, the RRP was larger in the <italic>Unc13a</italic> KO +PMA than in the <italic>Unc13a</italic> WT +PMA (169.2 fF ±37.9 fF vs RRP = 88.5 fF±11.9 fF), but the difference did not reach statistical significance. The SRP-size was significantly larger in the Unc13a KO +PMA than in the Unc13a WT +PMA group (<italic>Unc13a</italic> WT, SRP = 29.8 fF±7.9 fF,+PMA, SRP = 45.4 fF±7.0 fF, <italic>Unc13a</italic> KO, SRP = 40.5 fF±9.5 fF,+PMA, SRP = 95.6 fF±14.2 fF, Kruskal-Wallis test – Dunn’s multiple comparisons test: KO vs KO PMA p=0.0048; WT PMA vs KO PMA p=0.0437; WT vs KO PMA p=0.0003, <xref ref-type="fig" rid="fig2">Figure 2E</xref>). The sustained release and the kinetics of RRP and SRP fusion were not significantly different between conditions (<xref ref-type="fig" rid="fig2">Figure 2C, D and F</xref>). The hypothesis that PMA has a larger effect in Unc13a KO than in Unc13a WT can also be tested by arranging the data in a two-way ANOVA, with genotype and drug application (with or without PMA) as orthogonal factors. The hypothesis then becomes identifiable as a significant interaction between the two factors. Indeed, performing this analysis showed that the interaction was close to significant in both cases (p=0.0562 for RRP size and p=0.0442 for SRP size), indicating a likely interaction between the two factors, which was again significant for the SRP.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Absence of Munc13-1 potentiates phorbolester-induced secretion.</title><p>(<bold>A</bold>) Calcium uncaging experiment in <italic>Unc13a</italic> WT (black traces) and KO embryonic (E18) chromaffin cells (red traces) untreated or treated with PMA (WT-PMA: Blue traces; KO-PMA: Yellow traces). Panels are arranged as in <xref ref-type="fig" rid="fig1">Figure 1A</xref>. (<bold>B</bold>) Sizes of the RRP. (<bold>C</bold>) Time constants of fusion for fast (i.e. RRP) secretion. (<bold>D</bold>) Sustained secretion. (<bold>E</bold>) Sizes of the SRP. (<bold>F</bold>) Time constants of fusion for slow (i.e. SRP) secretion. In the absence of Munc13-1 (<italic>Unc13a</italic> KO), PMA potentiates secretion more than in <italic>Unc13a</italic> WT cells. Data information: In panel A (top panel), data are presented as mean ± SEM; in A (middle and bottom panels), the traces are the mean of all cells. In B-F, data are presented as box and whiskers. * p&lt;0.05; ** p&lt;0.01. Kruskal-Wallis test with Dunn’s post-hoc test. Number of cells in (<bold>A–F</bold>): WT: n=23 cells; KO: n=24 cells; WT +PMA: n=26 cells; KO +PMA: n=21 cells.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Quantitative data.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-79433-fig2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79433-fig2-v2.tif"/></fig><p>When comparing the two mouse lines, the secretory amplitude was larger in the <italic>Unc13b</italic> WT than in <italic>Unc13a</italic> WT, especially in the presence of PMA (<xref ref-type="fig" rid="fig2">Figure 2A</xref> vs <xref ref-type="fig" rid="fig1">Figure 1A</xref>). However, <italic>Unc13a</italic> WT and <italic>Unc13b</italic> WT cultures were not prepared in parallel. Moreover, because <italic>Unc13a</italic> is perinatally lethal (<xref ref-type="bibr" rid="bib6">Augustin et al., 1999a</xref>) we used embryonic animals (18. embryonic day) for <italic>Unc13a</italic> KO and WT, whereas for <italic>Unc13b</italic> WT and KO, we used postnatal (P0-P2) animals (Materials and Methods). The data sets are therefore not directly comparable.</p><p>Overall, phorbolester is more potent in the absence of Munc13-1, consistent with the notion that functional interaction of phorbolester with endogenous Munc13-1 interaction is negative for secretion in chromaffin cells.</p></sec><sec id="s2-3"><title>Overexpressed Munc13-1 and Munc13-2 display different trafficking and phorbolester effects</title><p>Next, we overexpressed each Munc13 paralog (Munc13-1, ubMunc13-2) separately, and investigated whether the effect of phorbolester would differ when either paralog would dominate the cell. These experiments made use of the Munc13-1-EGFP and ubMunc13-2-EGFP Semliki Forest Virus (SFV) constructs previously used for expression in bovine or mouse chromaffin cells (<xref ref-type="bibr" rid="bib5">Ashery et al., 2000</xref>; <xref ref-type="bibr" rid="bib53">Man et al., 2015</xref>; <xref ref-type="bibr" rid="bib98">Zikich et al., 2008</xref>). We took advantage of the EGFP-tag to visualize trafficking of Munc13 following Ca<sup>2+</sup>-uncaging using a CCD camera (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Thus, before and after the uncaging flash, cells were illuminated by 488 nm light to visualize EGFP. This was possible using the same (fura-containing) pipette solution, because 488 nm light does not excite fura dyes. Although in these measurements we did not measure [Ca<sup>2+</sup>]<sub>i</sub>, we could measure [Ca<sup>2+</sup>] in separate experiments using identical flash lamp setting, dichroic mirror, objective, and pipette solution (see Materials and Methods). Thereby, we established that these measurements led to a pre-stimulation [Ca<sup>2+</sup>]<sub>i</sub> = 0.64 µM±0.09 µM and a post-stimulation [Ca<sup>2+</sup>]<sub>i</sub> = 26.8 µM±1.8 µM (means ± SEM, n=14) (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Some measurements might deviate from this range. Successful expression of Munc13-1-EGFP and ubMunc13-2-EGFP was verified by Western blotting of SFV-infected HEK-cells (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A</xref>), and quantification of EGFP fluorescence from single chromaffin cells (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3B</xref>). We imaged Munc13-1-EGFP, ubMunc13-2-EGFP and the H567K-mutation of Munc13-1-EGFP, which does not bind to phorbolesters (<xref ref-type="bibr" rid="bib11">Betz et al., 1998</xref>), while applying PMA (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4</xref>). As expected, Munc13-1-EGFP and ubMunc13-2-EGFP, but not Munc13-1-EGFP H567K translocated to the plasma membrane over the course of several minutes. This time course most likely reflects the time it takes for PMA to penetrate the cell, combined with the time it takes for Munc13 to diffuse to the plasma membrane in the absence of increased [Ca<sup>2+</sup>]. Since the capacitance measurements above indicated that the main effect of PMA is on secretion amplitude, not kinetics (see also <xref ref-type="bibr" rid="bib60">Nagy et al., 2006</xref>), we simplified the analysis and only distinguished between burst secretion (first 1 s secretion after Ca<sup>2+</sup> uncaging, corresponding approximately to RRP and SRP fusion) and sustained secretion (last 4 s of secretion), as well as total secretion (the sum of burst and sustained release).</p><p>Expression of ubMunc13-2-EGFP in <italic>Unc13b</italic> KO cells resulted in large secretory amplitude, ~800 fF (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). In response to PMA, secretion was increased even further, resulting in an increase in burst size, total and sustained secretion; the two former effects were statistically significant (Burst - Overexpressed (OE) ubMunc13-2-EGFP: 239.09 fF ±25.96 fF,+PMA: 628.72 fF ±119.64 fF, Mann-Whitney test: p=0.0314; Total - OE ubMunc13-2 EGFP: 808.93 fF ±107.82 fF,+PMA: 1344.53 fF ±178.70 fF, Mann-Whitney test: p=0.0479; Sustained - OE ubMunc13-2-EGFP: 570.22 fF ±87.67 fF; 714.66±89.75, Mann-Whitney test: p=0.2992; <xref ref-type="fig" rid="fig3">Figure 3D</xref>). ubMunc13-2-EGFP was present in the cytosol (<xref ref-type="fig" rid="fig3">Figure 3A</xref> top panels), but upon uncaging, part of the protein trafficked to the plasma membrane within a few seconds, with a kinetics roughly matching sustained release - in <xref ref-type="fig" rid="fig3">Figure 3B</xref> the normalized PM fluorescence was replotted behind the capacitance trace to allow a comparison (<xref ref-type="fig" rid="fig3">Figure 3A–B</xref>; <xref ref-type="fig" rid="fig3s5">Figure 3—figure supplement 5A</xref>). Upon application of PMA, ubMunc13-2-EGFP was already at the plasma membrane and did not traffic further upon Ca<sup>2+</sup> increase (<xref ref-type="fig" rid="fig3">Figure 3A</xref> bottom panels, <xref ref-type="fig" rid="fig3">Figure 3B</xref>, <xref ref-type="fig" rid="fig3s5">Figure 3—figure supplement 5B</xref>). To test the significance of the Ca<sup>2+</sup>-dependent trafficking, we could use the trafficking index at 5 s compared to preflash values. However, in principle the uncaging flash itself could change our measure of PM localization (total fluorescence divided by fluorescence in the cytosol), because it represents a strong flash of ultraviolet light that could lead to bleaching of both EGFP and background fluorescence. If bleaching of EGFP and background are not exactly proportional, the measure of PM localization could change even in the absence of trafficking. Therefore, we compared trafficking at 5 s after uncaging in the absence of PMA to the PMA-group, since the PMA group did not show significant trafficking by virtue of being already at the plasma membrane. This showed that Ca<sup>2+</sup>-dependent trafficking was highly significant (Mann-Whitney test: p&lt;0.0001; <xref ref-type="fig" rid="fig3">Figure 3C</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>UbMunc13-2-dependent secretion is potentiated by phorbolester.</title><p>(<bold>A</bold>) Wide-field imaging of ubMunc13-2-EGFP expressed in <italic>Unc13b</italic> KO chromaffin cells and treated with PMA (orange) or left untreated (grey). ubMunc13-2 was recruited at the plasma membrane after calcium uncaging (Top panel - white arrows) and upon PMA treatment (bottom panels). The uncaging light flash is represented by a red arrow. Scale bar: 5 µm. (<bold>B</bold>) Top: Quantification of the plasma membrane ubMunc13-2-EGFP fluorescence intensity normalized to the first picture acquired in resting condition (mean ± SEM of all cells). Bottom: Capacitance traces (mean of all cells) obtained simultaneously with EGFP imaging, showing that PMA treatment potentiates secretion in <italic>Unc13b</italic> KO cells expressing ubMunc13-2. Right axis: Normalized PM fluorescence replotted from panel (<bold>A</bold>) showing that the time course coincides with the capacitance trace. (<bold>C</bold>) Plasma membrane ubMunc13-2-EGFP recruitment (total fluorescence / inside fluorescence) normalized to resting (pre-stimulation) values. (<bold>D</bold>) Sizes of Burst, Total and Sustained release. Data information: data in panel B are presented as mean ± SEM; data in panels C and D are presented as box and whiskers. *: p&lt;0.05; ****: p&lt;0.0001, Mann-Whitney tests. ubMunc13-2-EGFP in <italic>Unc13b</italic> KO: n=25 cells; ubMunc13-2-EGFP in <italic>Unc13b</italic> KO +PMA: n=30 cells.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Quantitative data.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-79433-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79433-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Experimental setup combining capacitance measurements and GFP-imaging in adrenal chromaffin cells.</title><p>(Top:) Stimulation of secretion by ultraviolet flash photolysis of caged-calcium (Nitrophenyl-EGTA: NPE). Upon stimulation, NPE is cleaved, releasing free Ca<sup>2+</sup>. The amount of calcium released upon flash photolysis is calibrated before the experiments by adjusting the intensity of the flash lamp. Middle: Capacitance measurements: the whole-cell patch clamp configuration was used to perform capacitance measurements. Lower: UV flash-lamp / Monochromator light are directed towards the filtercube that contains a dichroic mirror. The mirror reflects the light for calcium-uncaging, Ca<sup>2+</sup> measurements and for GFP-fluorescence picture acquisition. In the emission pathway, light is directed either to a camera (for GFP fluorescence imaging), or towards a photodiode (for Ca<sup>2+</sup> measurements). On this setup, GFP-fluorescence imaging and photometry cannot be performed simultaneously.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79433-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Calcium concentration before and after UV flash photolysis of nitrophenyl-EGTA.</title><p>(<bold>A</bold>) Calcium uncaging experiment in CD1 WT cells. Top panel: [Ca<sup>2+</sup>] (mean ± SEM) before (insert) and after calcium uncaging (uncaging flash at red arrow, bottom panel). Bottom panel: capacitance traces (mean of all cells). In the setup depicted in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>, GFP-imaging cannot be carried out simultaneously with photometry. Therefore, we performed a calcium uncaging experiment using photometry to measure calcium concentrations under identical conditions as in GFP-imaging experiments. Thereby, we determined the average pre-flash and post-flash calcium concentrations with the current settings (for values, see main text). n=14 cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79433-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Expression levels of Munc13-1-EGFP and ubMunc13-2-EGFP.</title><p>(<bold>A</bold>) Western blot of HEK-cells expressing ubMunc13-2-EGFP, or Munc13-1-EGFP, or left uninfected. Expression was induced by infection with Semliki Forest Virus. The membrane was blotted with rabbit polyclonal α-GFP. As expected, Munc13-1-EGFP is slightly larger than ubMunc13-2-EGFP. β-actin was used as loading control. (<bold>B</bold>) Quantification of EGFP-fluorescence of single mouse chromaffin cells infected with similar quantities of Semliki Forest Virus encoding either Munc13-1 or ubMunc13-2. Munc13-1-EGFP was on average expressed in higher amounts. *: p&lt;0.05. Mann-Whitney test comparing Munc13-1 KO cells overexpressing Munc13-1-EGFP and Munc13-2 KO cells overexpressing Munc13-2-EGFP. OEMunc13-1-EGFP: N=21 cells; OE Munc13-2-EGFP: N=25 cells.</p><p><supplementary-material id="fig3s3sdata1"><label>Figure 3—figure supplement 3—source data 1.</label><caption><title>Western blots, raw and with bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-79433-fig3-figsupp3-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig3s3sdata2"><label>Figure 3—figure supplement 3—source data 2.</label><caption><title>Quantitative data.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-79433-fig3-figsupp3-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79433-fig3-figsupp3-v2.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 4.</label><caption><title>PMA-induced recruitment of overexpressed Munc13 proteins to the plasma membrane in WT mouse adrenal chromaffin cells.</title><p>(<bold>A</bold>) Wide-field imaging of overexpressed ubMunc13-1-EGFP, Munc13-1-EGFP and Munc13-1-H567K-EGFP in wildtype cells (CD1 expressing ubMunc13-1-EGFP – Orange, CD1 WT expressing Munc13-1-EGFP – Green, CD1 WT expressing Munc13-1-H567K-EGFP – Grey) mouse adrenal chromaffin cells. Munc13-1-H567K-EGFP was not recruited to the plasma membrane after PMA treatment. PMA treatment is represented by the red arrow. Scale bar: 5 µm. (<bold>B</bold>) Quantification of the plasma membrane fluorescence intensity normalized to the first picture acquired under resting condition (OE ubMunc13-2-EGFP: n=3 cells; OE Munc13-1-EGFP: n=3 cells; OE Munc13-1-H567K-EGFP: n=3 cells).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79433-fig3-figsupp4-v2.tif"/></fig><fig id="fig3s5" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 5.</label><caption><title>ubMunc13-2 trafficking in individual chromaffin cells.</title><p>(<bold>A</bold>) Individual fluorescence traces of EGFP localization in ubMunc13-2-EGFP expressing cells, after Ca<sup>2+</sup> uncaging (individual traces underlying average graph in <xref ref-type="fig" rid="fig3">Figure 3B</xref>, top panel, grey symbols). (<bold>B</bold>) Individual fluorescence traces of EGFP localization in ubMunc13-2-EGFP expressing cells treated with PMA, after Ca2 +uncaging (individual traces underlying average graph in <xref ref-type="fig" rid="fig3">Figure 3B</xref>, top panel, orange symbols).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79433-fig3-figsupp5-v2.tif"/></fig></fig-group><p>Expression of Munc13-1-EGFP in <italic>Unc13a</italic> KO cells resulted in approximately 400 fF secretion (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), more than in the <italic>Unc13a</italic> WT (<xref ref-type="fig" rid="fig2">Figure 2</xref>), although we here compare experiments not carried out in parallel. Munc13-1-EGFP localized to the cytosol, with part of the protein found in larger accumulations in some, but not all cells (compare different examples in <xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). We speculated that the accumulations might be related to the higher average expression level of Munc13-1 compared to ubMunc13-2, as assessed by cellular EGFP fluorescence (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3B</xref>). Expression of the Munc13-1-EGFP for shorter times (than the standard 12–17 hr, Materials and methods) was attempted, but this was not successful because of a lack of consistent expression as detected by EGFP fluorescence. Upon PMA application, part of the protein localized to the plasma membrane (<xref ref-type="fig" rid="fig4">Figure 4A</xref>; <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4</xref>). As a further indication that Munc13-1-EGFP is functional, we expressed it in cells from CD1-mice (an outbred mouse strain). Expression caused a clear and statistically significant increase in total and sustained secretion (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). We verified the sequence of both the Munc13-1-EGFP and ubMunc13-2-EGFP expression plasmids (Materials and Methods). Although some individual cells displayed EGFP-Munc13-1 trafficking (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>), overall little membrane trafficking was induced by increasing calcium in Munc13-1-EGFP expressing cells (<xref ref-type="fig" rid="fig4">Figure 4B–C</xref>). Following PMA-application, total, burst and sustained secretion were reduced; the effects on total and burst secretion were statistically significant (Burst - OE Munc13-1-EGFP: 136.92 fF ±26.09 fF,+PMA: 68.34 fF ±9.10 fF, Mann-Whitney test: p=0.0117; Total - OE Munc13-1-EGFP: 414.22 fF ±69.47 fF,+PMA: 219.53 fF ±34.35 fF, Mann-Whitney test: p=0.0182; Sustained - OE Munc13-1-EGFP: 273.30 fF ±52.75 fF; 150.9±32.07, Mann-Whitney test: p=0.0793; <xref ref-type="fig" rid="fig4">Figure 4B and D</xref>). These data indicate that PMA-induced stimulation of Munc13-1 is inhibitory for DV secretion in chromaffin cells, in agreement with findings above in the <italic>Unc13a</italic> and <italic>Unc13b</italic> mouse lines. As a control, we expressed the Munc13-1 H567K mutation, which does not bind to phorbolesters (<xref ref-type="bibr" rid="bib11">Betz et al., 1998</xref>) in adrenal chromaffin cells from CD1 mice. Upon expression, there was no effect of PMA (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>), which agrees with previous data from bovine chromaffin cells (<xref ref-type="bibr" rid="bib10">Bauer et al., 2007</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Munc13-1-dependent secretion is inhibited by phorbolester.</title><p>(<bold>A</bold>) Wide-field imaging of Munc13-1-EGFP expressed in <italic>Unc13a</italic> KO chromaffin cells treated with PMA (green) or left untreated (grey). Munc13-1-EGFP was not recruited at the plasma membrane after calcium uncaging (top panel) but was present at the PM upon PMA treatment (bottom panel). The uncaging light flash is represented by a red arrow. Scale bar: 5 µm. (<bold>B</bold>) Top: Quantification of the plasma membrane Munc13-1-EGFP fluorescence intensity normalized to the first picture acquired in resting condition (mean ± SEM of all cells). Bottom: Capacitance traces (mean of all cells) obtained simultaneously with EGFP imaging, showing that PMA treatment reduces secretion in <italic>Unc13a</italic> KO cells overexpressing Munc13-1. (<bold>C</bold>) Plasma membrane Munc13-1-EGFP recruitment (total fluorescence / inside fluorescence) normalized to resting (pre-stimulation) values. (<bold>D</bold>) Sizes of Burst, Total and Sustained release. Data information: data in panel B are presented as mean ± SEM; data in panels C and D are presented as box and whiskers. *: p&lt;0.05, Mann-Whitney tests. OE Munc13-1-EGFP: n=21 cells; OE Munc13-1-EGFP+PMA: n=21 cells.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Quantitative data.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-79433-fig4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79433-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Munc13-1 overexpression potentiates secretion in WT mouse adrenal chromaffin cells.</title><p>(<bold>A</bold>) Wide-field imaging of overexpressed Munc13-1-EGFP in wildtype (CD1 WT – Grey; CD1 WT expressing Munc13-1-EGFP) mouse adrenal chromaffin cells. Munc13-1-EGFP was not recruited at the plasma membrane after calcium uncaging. Uncaging flash is represented by the red arrow. Scale bar: 5 µm. (<bold>B</bold>) Top: Quantification of the plasma membrane fluorescence intensity normalized to the first picture acquired under resting condition. Bottom: capacitance traces (mean of all cells) obtained simultaneously with EGFP imaging show that overexpression of Munc13-1 potentiates secretion in WT cells. (<bold>C</bold>) Total plasma membrane Munc13-1-EGFP recruitment. (<bold>D</bold>) Sizes of Burst, Total and Sustained release. (<bold>E</bold>) Sizes of the RRP. (<bold>F</bold>) Time constants of fusion for fast (i.e. RRP) secretion. (<bold>G</bold>) Sustained secretion (secretion during the last 4 s of the trace in <bold>A</bold>).(<bold>H</bold>) Sizes of the SRP. (<bold>I</bold>) Time constants of fusion for slow (i.e. SRP) secretion. Data information: data in panel B are presented as mean ± SEM; data in panels C-I are presented as box and whiskers. *: p&lt;0.05. *p&lt;0.01. Mann-Whitney. WT cells: N=17 cells; OE Munc13-1-EGFP: N=18 cells.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Quantitative data.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-79433-fig4-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79433-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Munc13-1 trafficking in individual chromaffin cells.</title><p>(<bold>A</bold>) Individual fluorescence traces of EGFP localization in Munc13-1-EGFP expressing cells, after Ca<sup>2+</sup> uncaging (individual traces underlying average graph in <xref ref-type="fig" rid="fig4">Figure 4B</xref>, top panel, grey symbols). (<bold>B</bold>) Individual fluorescence traces of EGFP localization in Munc13-1-EGFP expressing cells treated with PMA, after Ca<sup>2+</sup> uncaging (individual traces underlying average graph in <xref ref-type="fig" rid="fig4">Figure 4B</xref>, top panel, green symbols).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79433-fig4-figsupp2-v2.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>PMA treatment of WT mouse adrenal chromaffin cells overexpressing Munc13-1 H567K does not change secretion.</title><p>(<bold>A</bold>) Wide-field imaging of overexpressed Munc13-1-H567K-EGFP in wildtype (CD1 WT – Grey; CD1 WT expressing Munc13-1-H567K-EGFP – Blue) mouse adrenal chromaffin cells. Munc13-1-H567K EGFP was not recruited at the plasma membrane after calcium uncaging or PMA treatment. Uncaging flash is represented by the red arrow. Scale bar: 5 µm. (<bold>B</bold>) Top: Quantification of the plasma membrane fluorescence intensity normalized to the first picture acquired under resting condition. Bottom: capacitance traces (mean of all cells) obtained simultaneously with EGFP imaging show that overexpression of Munc13-1-H567K do not change secretion in WT cells. (<bold>C</bold>) Total plasma membrane Munc13-1-H567K-EGFP recruitment. (<bold>D</bold>) Sizes of Burst, Total and Sustained release. Data information: data in panel B are presented as mean ± SEM; data in panels C and D are presented as box and whiskers. Mann-Whitney tests comparing WT cells with WT cells overexpressing Munc13-1-H567K-EGFP were insignificant. OE Munc13-1-H567K-EGFP: N=15 cells; OE Munc13-1-H567K-EGFP PMA: N=15 cells.</p><p><supplementary-material id="fig4s3sdata1"><label>Figure 4—figure supplement 3—source data 1.</label><caption><title>Quantitative data.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-79433-fig4-figsupp3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79433-fig4-figsupp3-v2.tif"/></fig></fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Munc13-1-dependent secretion is inhibited by phorbolester in the absence of ubMunc13-2.</title><p>(<bold>A</bold>) Wide-field imaging of Munc13-1-EGFP expressed in <italic>Unc13b</italic> KO chromaffin cells and treated with PMA (red) or left untreated (grey). Munc13-1-EGFP was not recruited at the plasma membrane after calcium uncaging (top panel) but was present at the PM upon PMA treatment (bottom panel). The uncaging light flash is represented by a red arrow. Scale bar: 5 µm. (<bold>B</bold>) Top: Quantification of the plasma membrane Munc13-1-EGFP fluorescence intensity normalized to the first picture acquired in resting condition (mean ± SEM of all cells). Bottom: Capacitance traces (mean of all cells) obtained simultaneously with EGFP imaging, showing that PMA treatment reduces secretion in <italic>Unc13b</italic> KO cells overexpressing Munc13-1-EGFP. (<bold>C</bold>) Plasma membrane Munc13-1-EGFP recruitment. (<bold>D</bold>) Sizes of Burst, Total and Sustained release. Data information: data in panel B are presented as mean ± SEM; data in panels C and D are presented as box and whiskers. ***: p&lt;0.001; ****: p&lt;0.0001, Mann-Whitney tests. OE Munc13-1-EGFP: n=18 cells; OE Munc13-1-EGFP+PMA: n=19 cells.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Quantitative data.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-79433-fig5-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79433-fig5-v2.tif"/></fig><p>Thus, evidence from both Munc13-1-EGFP overexpression and <italic>Unc13a</italic> KO as well as <italic>Unc13b</italic> KO indicate that PMA interacting with Munc13-1 is inhibitory, whereas PMA interacting with ubMunc13-2 is positive for DV secretion. Since ubMunc13-2 supports more secretion than Munc13-1 upon overexpression in parallel experiments (<xref ref-type="bibr" rid="bib53">Man et al., 2015</xref>), it is possible that the apparent negative effect of Munc13-1 could be due to competition with ubMunc13-2, because targeting Munc13-1 to the plasma membrane with PMA might displace the more potent ubMunc13-2. To investigate this, we expressed Munc13-1-EGFP in <italic>Unc13b</italic> KO cells (<xref ref-type="fig" rid="fig5">Figure 5A–D</xref>). Even under these circumstances, PMA application led to a significant decrease in total and sustained secretion, but the secretory burst was now unaffected (Burst - OE Munc13-1-EGFP: 104.64 fF ±20.58 fF,+PMA: 104.47 fF ±18.30 fF, Mann-Whitney test: p=0.8280; Total - OE Munc13-1-EGFP: 452.45 fF ±62.21 fF,+PMA: 210.43 fF ±50.40 fF, Mann-Whitney test: p&lt;0.0001; Sustained - OE Munc13-1-EGFP: 347.8 fF ±63.42 fF;+PMA: 106±38.75, Mann-Whitney test: p=0.0001; <xref ref-type="fig" rid="fig5">Figure 5D</xref>). Thus, the ability of PMA and Munc13-1 to suppress the burst might be due to displacement of ubMunc13-2, but ubMunc13-2 is not required for the overall inhibitory nature of PMAs interaction with Munc13-1.</p></sec><sec id="s2-4"><title>Synaptotagmin-7, ubMunc13-2 and phorbolester form a stimulatory triad for vesicle fusion</title><p>We previously showed that Syt7 is involved in calcium and phorbolester-induced priming of chromaffin cells DVs (<xref ref-type="bibr" rid="bib88">Tawfik et al., 2021</xref>). We here set out to understand whether the different abilities of ubMunc13-2 and Munc13-1 to support DV secretion in the presence of PMA depends on syt7.</p><p>We first expressed ubMunc13-2-EGFP in <italic>Syt7</italic> KO and WT cells. As previously reported (<xref ref-type="bibr" rid="bib88">Tawfik et al., 2021</xref>), expression of ubMunc13-2 resulted in massive secretion in both the <italic>Syt7</italic> KO and WT, but secretion was delayed in <italic>Syt7</italic> KO (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). As a result, the burst size, as defined by secretion within the first second, was significantly reduced in <italic>Syt7</italic> KO cells expressing EGFP-ubMunc13-2 compared to <italic>Syt7</italic> WT expressing EGFP-ubMunc13-2 (Burst - OE ubMunc13-2-eGFP in <italic>Syt7</italic> WT: 317.01 fF ±53.24 fF, OE Munc13-2-EGFP in <italic>Syt7</italic> KO: 150.21 fF ±24.91 fF, Mann-Whitney test: p=0.0286, <xref ref-type="fig" rid="fig6">Figure 6D</xref>; for other values see Source Data File). Imaging showed that in spite of the delayed secretion in the <italic>Syt7</italic> KO, ubMunc13-2-EGFP trafficking was unchanged (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>), and – consequently – ubMunc13-2-EGFP trafficking preceded exocytosis in the <italic>Syt7</italic> KO ubMunc13-2 overexpressing cells (<xref ref-type="fig" rid="fig6">Figure 6B</xref> bottom panel). Therefore, calcium-dependent ubMunc13-2-EGFP trafficking is independent of Syt7. To investigate this further, we performed co-immunoprecipations between b/ubMunc13-2 and Syt7, as well as between Munc13-1 and Syt7 (Materials and methods). However, we failed to identify any interaction (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). Therefore, any functional interaction between Syt7 and Munc13-2 does not seem to involve direct stable binding or co-trafficking, but transient interactions cannot be ruled out.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Ca<sup>2+</sup>-dependent recruitment of ubMunc13-2 is independent of Synaptotagmin-7.</title><p>(<bold>A</bold>) Wide-field imaging of ubMunc13-2-EGFP expressed in <italic>Syt7</italic> KO (grey) or <italic>Syt7</italic> WT cells (blue) chromaffin cells. ubMunc13-2-EGFP is recruited to the plasma membrane after calcium uncaging in the presence or absence of Syt7 (white arrows). The uncaging light flash is represented by a red arrow. Scale bar: 5 µm. (<bold>B</bold>) Top: Quantification of the plasma membrane ubMunc13-2-EGFP fluorescence intensity normalized to the first picture acquired in resting condition (mean ± SEM of all cells). Bottom: Capacitance traces (mean of all cells) obtained simultaneously with EGFP imaging show a delay in secretion in <italic>Syt7</italic> KO cells overexpressing ubMunc13-2-EGFP. Right axis: Normalized PM fluorescence replotted from panel (<bold>A</bold>) showing that the time course of ubMunc13-2 precedes the capacitance trace. (<bold>C</bold>) Plasma membrane ubMunc13-2-EGFP recruitment. (<bold>D</bold>) Sizes of the Burst, Total and Sustained release. Data information: data in panel B are presented as mean ± SEM; data in panels C and D are presented as box and whiskers. *: p&lt;0.05, Mann-Whitney test. <italic>Syt7</italic> KO OE ubMunc13-2-EGFP: n=21 cells; <italic>Syt7</italic> WT OE ubMunc13-2-EGFP PMA: n=22 cells.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Quantitative data.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-79433-fig6-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79433-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Syt-7 is not co-immunoprecipitated with Munc13-2 or Munc13-1.</title><p>(<bold>A</bold>) Co-immunoprecipitation of endogenous Syt7 with Munc13-2-EYFP. Soluble protein extracts from mouse brain expressing Munc13-2-EYFP were subjected to the GFP-Trap assay, in the presence or absence of 1 mM Ca<sup>2+</sup>. Samples of the protein extracts used in the immunoprecipitation (input), supernatant (non-bound) and eluted supernatant containing possible immunocomplexes (bound) were processed by SDS-PAGE followed by Western Blot analysis. Western blot was performed using antibodies to detect the proteins indicated on the left. (<bold>B</bold>) Co-immunoprecipitation of endogenous Syt7 with Munc13-1. A home-made mouse monoclonal α-Munc13-1 was attached to Sepharose-Protein G beads. Brain protein extracts from WT mice were incubated with the beads, washed and eluted (‘IP’ samples) and resolved on Bis-Tris polyacrylamide genes, together with the original sample (‘input’).</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Western blots, raw and with bands.</title><p>Note that the file marked Figure 6-Figure supplement 1 - source data 6 contains two blots unrelated to the present manuscript.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-79433-fig6-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79433-fig6-figsupp1-v2.tif"/></fig></fig-group><p>To shed further light on the interaction between PMA, Munc13-2 and Syt7, we applied PMA to <italic>Syt7</italic> KO cells expressing ubMunc13-2-EGFP (<xref ref-type="fig" rid="fig7">Figure 7</xref>). Strikingly, in these cells, PMA was strongly inhibitory for secretion (<xref ref-type="fig" rid="fig7">Figure 7D</xref>), leading to a statistically significant decrease in total and sustained secretion, whereas the burst was non-significantly reduced (Burst - OE ubMunc13-2-EGFP in <italic>Syt7</italic> KO: 220.51 fF ±51.60 fF,+PMA: 185.45 fF ±53.19 fF, Mann-Whitney test: p=0.3989; Total - OE ubMunc13-2-EGFP in <italic>Syt7</italic> KO: 896.60 fF ±199.86 fF,+PMA: 223.03 fF ±53.60 fF, Mann-Whitney test: p=0.0002; Sustained - OE ubMunc13-2-EGFP in <italic>Syt7</italic> KO: 676.34 fF ±156.89 fF;+PMA: 37.43±15.53, Mann-Whitney test: p&lt;0.0001; <xref ref-type="fig" rid="fig7">Figure 7D</xref>). Similar to data obtained above, ubMunc13-2 trafficked to the PM after a calcium increase (<xref ref-type="fig" rid="fig7">Figure 7A–C</xref>). In a final experiment, we showed that in <italic>Syt7</italic> KO cells expressing Munc13-1, PMA was also inhibitory for both total and sustained secretion (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). Overall, the difference between Munc13-1 and ubMunc13-2 in their response to PMA lies in the specific ability of ubMunc13-2 to interact productively with Syt7; in the absence of Syt7, PMA interacting with ubMunc13-2 is negative for secretion, as is the case for Munc13-1.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>In the absence of Synaptotagmin-7, ubMunc13-2-dependent secretion is inhibited by phorbolester.</title><p>(<bold>A</bold>) Wide-field imaging of overexpressed ubMunc13-2-EGFP expressed in <italic>Syt7</italic> KO chromaffin cells treated with PMA (pink) or left untreated (grey). ubMunc13-2-EGFP was recruited to the plasma membrane after calcium uncaging, and was found at the plasma membrane upon PMA treatment. The uncaging light flash is represented by a red arrow. Scale bar: 5 µm. (<bold>B</bold>) Top: Quantification of the plasma membrane ubMunc13-2-EGFP fluorescence intensity normalized to the first picture acquired in resting condition (mean ± SEM of all cells). Bottom: Capacitance traces (mean of all cells) obtained simultaneously with EGFP imaging in <italic>Syt7</italic> KO cells expressing ubMunc13-2-EGFP in the absence and presence of PMA. Upon exposure to PMA, secretion in ubMunc13-2 expressing <italic>Syt7 KO</italic> cells was strongly inhibited. (<bold>C</bold>) Plasma membrane ubMunc13-2-EGFP recruitment. (<bold>D</bold>) Sizes of Burst, Total and Sustained release. Data information: data in panel B are presented as mean ± SEM; data in panels C and D are presented as box and whiskers.*: p&lt;0.05; ***: p&lt;0.001; ****: p&lt;0.0001, Mann-Whitney tests. OE ubMunc13-2-EGFP in <italic>Syt7</italic> KO: n=14 cells;+PMA: n=17 cells.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Quantitative data.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-79433-fig7-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79433-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Munc13-1 inhibits secretion independently of Syt7.</title><p>(<bold>A</bold>) Wide-field imaging of Munc13-1-EGFP expressed in <italic>Syt7</italic> KO mice cells treated (Orange) with PMA or left untreated (Blue). Munc13-1-EGFP was not recruited at the plasma membrane after calcium uncaging but was relocalized to the plasma membrane upon PMA treatment. Uncaging flash is represented by a red arrow. Scale bar: 5 µm. (<bold>B</bold>) Top: Quantification of the plasma membrane fluorescence intensity normalized to the first picture acquired under resting condition. Bottom: Capacitance traces (mean of all cells) obtained simultaneously with EGFP imaging shows that in <italic>Syt7</italic> KO cells overexpressing Munc13-1-EGFP, PMA inhibits secretion and reverses it back to the level of non-overexpressing <italic>Syt7</italic> KO cells. (<bold>C</bold>) Total plasma membrane Munc13-1-EGFP recruitment. (<bold>D</bold>) Sizes of Burst, Total and Sustained release. Data information: data in panel B are presented as mean ± SEM; data in panels C and D are presented as box and whiskers. *: p&lt;0.05. Mann-Whitney tests comparing <italic>Syt7</italic> KO with <italic>Syt7</italic> KO overexpressing Munc13-1-EGFP or <italic>Syt7</italic> KO overexpressing Munc13-1-EGFP treated with PMA. <italic>Syt7</italic> KO: N=16 cells; <italic>Syt7</italic> KO OE Munc13-1: N=14 cells; Syt-7 WT OE Munc13-1 PMA: N=19 cells.</p><p><supplementary-material id="fig7s1sdata1"><label>Figure 7—figure supplement 1—source data 1.</label><caption><title>Quantitative data.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-79433-fig7-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79433-fig7-figsupp1-v2.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>PKC inhibition does not affect membrane fusion in the presence or absence of ubMunc13-2.</title><p>(<bold>A</bold>) Calcium uncaging experiment in <italic>Unc13b</italic> WT (black traces) and KO embryonic chromaffin cells (red traces) untreated or treated with an inhibitor of PKC (Gö6983) (WT- Gö6983: Blue traces; KO- Gö6983: Yellow traces). Panels are arranged as in <xref ref-type="fig" rid="fig1">Figure 1A</xref>. (<bold>B</bold>) Sizes of the RRP. (<bold>C</bold>) Time constants of fusion for fast (i.e. RRP) secretion. (<bold>D</bold>) Sustained secretion. (<bold>E</bold>) Sizes of the SRP. (<bold>F</bold>) Time constants of fusion for slow (i.e. SRP) secretion. Pharmacological inhibition of PKC did not change membrane fusion as measured by capacitance increase, in the presence or absence of ubMunc13-2. Note that release of adrenaline/noradrenaline was blocked by the Gö6983 inhibitor, which is reflected in a reduction in the amperometric current (see also <xref ref-type="bibr" rid="bib23">Fulop and Smith, 2006</xref>, Biochem. J. 399, 111–119). Data information: data in panel B are presented as mean ± SEM; data in panels C and D are presented as box and whiskers. Mann-Whitney tests comparing <italic>Unc13b</italic> WT with <italic>Unc13b</italic> WT +Gö6983 or <italic>Unc13b</italic> KO with <italic>Unc13b</italic> KO +Gö6983. Number of cells in (<bold>A–F</bold>): WT: n=27 cells; KO: n=18 cells; WT +Gö6983: n=25 cells; KO +Gö6983: n=19 cells.</p><p><supplementary-material id="fig7s2sdata1"><label>Figure 7—figure supplement 2—source data 1.</label><caption><title>Quantitative data.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-79433-fig7-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79433-fig7-figsupp2-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Previous investigations did not resolve the function of Munc13-1 in chromaffin cells, since no consequences of eliminating Munc13-1 were identified (<xref ref-type="bibr" rid="bib53">Man et al., 2015</xref>), while other studies showed that overexpression of Munc13-1 increased secretion in bovine chromaffin cells (<xref ref-type="bibr" rid="bib5">Ashery et al., 2000</xref>; <xref ref-type="bibr" rid="bib12">Betz et al., 2001</xref>) or mouse <italic>Unc13a</italic>/<italic>Unc13b</italic> double knockout chromaffin cells (<xref ref-type="bibr" rid="bib53">Man et al., 2015</xref>). Here, we reproduced the positive effect of Munc13-1 overexpression in WT cells (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>), but the increase in burst secretion was smaller in our hands than reported earlier upon expression in bovine chromaffin cells (<xref ref-type="bibr" rid="bib5">Ashery et al., 2000</xref>; <xref ref-type="bibr" rid="bib12">Betz et al., 2001</xref>). This can be due to differences in species or age of the experimental animals (embryonic/newborn mice vs adult cow). It might also be due to differences in prestimulation Ca<sup>2+</sup> concentrations, which were not measured in each cell in our experiment and not measured in the work on bovine cells. We also reproduced the lack of consequences of Munc13-1 elimination (<xref ref-type="fig" rid="fig2">Figure 2</xref>; <xref ref-type="bibr" rid="bib53">Man et al., 2015</xref>). However, we surprisingly found that the dominating Munc13 paralog determines the effect of phorbolester (PMA), such that PMA is inhibitory when Munc13-1 dominates, but stimulatory when ubMunc13-2 is prevalent. The evidence supporting this conclusion is:</p><list list-type="order"><list-item><p>In the <italic>Unc13b</italic> WT mouse, PMA was stimulatory for secretion, in agreement with the higher endogenous expression level of ubMunc13-2 than Munc13-1 (<xref ref-type="bibr" rid="bib53">Man et al., 2015</xref>). In <italic>Unc13b</italic> KO mouse (expressing endogenous Munc13-1, but no ubMunc13-2), PMA became inhibitory for secretion.</p></list-item><list-item><p>In the <italic>Unc13a</italic> KO mouse, PMA was more stimulatory for secretion than in the <italic>Unc13a</italic> WT mouse, consistent with a negative function for endogenous Munc13-1 in the presence of PMA.</p></list-item><list-item><p>Upon overexpression of ubMunc13-2, PMA was stimulatory for secretion (as in WT cells).</p></list-item><list-item><p>Upon overexpression of Munc13-1, PMA became inhibitory for secretion, whether overexpression was in <italic>Unc13a</italic> KO (still expressing ubMunc13-2) or in <italic>Unc13b</italic> KO cells.</p></list-item></list><p>The identification of opposite effects of phorbolester for DV secretion depending on the predominant expression of Munc13-1 and ubMunc13-2 is surprising, given their ability to cross-rescue (<xref ref-type="bibr" rid="bib53">Man et al., 2015</xref>; <xref ref-type="bibr" rid="bib73">Rosenmund et al., 2002</xref>). However, a difference in phorbolester-effect of Munc13-1 and ubMunc13-2 was detected before, as the positive effect of phorbolester on synaptic release was larger in ubMunc13-2 than in Munc13-1 expressing <italic>Unc13a</italic>/<italic>Unc13b</italic> double KO glutamatergic neurons (<xref ref-type="bibr" rid="bib73">Rosenmund et al., 2002</xref>). Nevertheless, phorbolester interacting with Munc13-1 is clearly stimulatory for glutamate release (<xref ref-type="bibr" rid="bib73">Rosenmund et al., 2002</xref>).</p><p>The effect of phorbolester on Munc13s is partly to recruit the protein to the plasma membrane by binding to the C1-domain, and partly to release an inhibitory effect of the (DAG and Ca<sup>2+</sup> unbound) C1-C2B domain (<xref ref-type="bibr" rid="bib56">Michelassi et al., 2017</xref>). Previous findings in chromaffin cells showed that overexpression of Doc2B boosts the secretory burst, which required an intact Munc13-binding domain (the MID domain <xref ref-type="bibr" rid="bib22">Friedrich et al., 2013</xref>; <xref ref-type="bibr" rid="bib56">Michelassi et al., 2017</xref>) and the presence of ubMunc13-2, making it possible for Doc2B to target ubMunc13-2 to the plasma membrane (<xref ref-type="bibr" rid="bib64">Orita et al., 1997</xref>). However, in the absence of ubMunc13-2 (i.e. in <italic>Unc13b</italic> KO cells), overexpression of Doc2B became strongly inhibitory (<xref ref-type="bibr" rid="bib28">Houy et al., 2017</xref>). This inhibitory function of Doc2B aligns with its ability to target Munc13-1 (present in <italic>Unc13b</italic> KO cells) to the plasma membrane (<xref ref-type="bibr" rid="bib22">Friedrich et al., 2013</xref>; <xref ref-type="bibr" rid="bib28">Houy et al., 2017</xref>) and agrees with our findings here that plasma membrane targeting of Munc13-1 by PMA is inhibitory for chromaffin cell DV secretion.</p><p>Apart from its ability to bind Munc13s, phorbolester also activates protein kinase C (PKC), which has effects on chromaffin cell excitability, calcium homeostasis, and secretion (<xref ref-type="bibr" rid="bib23">Fulop and Smith, 2006</xref>; <xref ref-type="bibr" rid="bib41">Kuri et al., 2009</xref>; <xref ref-type="bibr" rid="bib67">Park et al., 2006</xref>; <xref ref-type="bibr" rid="bib74">Rosmaninho-Salgado et al., 2007</xref>; <xref ref-type="bibr" rid="bib81">Smith et al., 1998</xref>; <xref ref-type="bibr" rid="bib82">Soma et al., 2009</xref>; <xref ref-type="bibr" rid="bib85">Staal et al., 2008</xref>). Using whole-cell voltage clamp and calcium-uncaging, effects on excitability and calcium homeostasis are effectively bypassed, allowing us to focus on the secretory machinery in the present study. In neurons, the effects of phorbolester have been attributed both to Munc13-1 C1-activation, and PKC-activation (<xref ref-type="bibr" rid="bib70">Rhee et al., 2002</xref>; <xref ref-type="bibr" rid="bib95">Wierda et al., 2007</xref>). PKC phosphorylates exocytotic proteins, including Munc18-1 (<xref ref-type="bibr" rid="bib24">Genc et al., 2014</xref>; <xref ref-type="bibr" rid="bib95">Wierda et al., 2007</xref>) and synaptotagmin-1 (<xref ref-type="bibr" rid="bib20">de Jong et al., 2016</xref>), and these phosphorylation events are required for full potentiation of synaptic transmission after train stimulation or PMA application, respectively (but see <xref ref-type="bibr" rid="bib94">Wang et al., 2021b</xref>). Phosphorylation of Munc18-1 also potentiates secretion from adult bovine chromaffin cells (<xref ref-type="bibr" rid="bib63">Nili et al., 2006</xref>). However, PKC-dependent modulation of the release machinery appears weaker or absent in embryonic or newborn mouse chromaffin cells, since blocking Munc18-1 or synaptotagmin-1 phosphorylation have no detectable consequences, either in control conditions, or after PMA application (<xref ref-type="bibr" rid="bib60">Nagy et al., 2006</xref>; <xref ref-type="bibr" rid="bib63">Nili et al., 2006</xref>). Furthermore, we have shown that blocking PKC-activity has no consequences for capacitance increases during Ca<sup>2+</sup>-uncaging in chromaffin cells, if only one Ca<sup>2+</sup>-stimulation is used (<xref ref-type="bibr" rid="bib59">Nagy et al., 2002</xref>; <xref ref-type="bibr" rid="bib63">Nili et al., 2006</xref>). We confirmed that here for both <italic>Unc13b</italic> WT and KO cells, using a broad spectrum PKC inhibitor (Gö6983, <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>). However, although membrane fusion was unaffected, the amperometric signal was reduced, reflecting a reduced release of adrenaline/noradrenaline – this effect of PKC inhibition was noted before (<xref ref-type="bibr" rid="bib23">Fulop and Smith, 2006</xref>; <xref ref-type="bibr" rid="bib85">Staal et al., 2008</xref>). These observations are in agreement with our finding that Munc13-2 is absolutely required for the stimulatory effect of phorbolester on capacitance increase (<xref ref-type="fig" rid="fig1">Figure 1</xref>); however, we cannot rule out an interaction between PKC-dependent phosphorylation and Munc13 activation.</p><p>Even though overexpression of ubMunc13-2 results in the most potent secretion from chromaffin cells so far known (<xref ref-type="bibr" rid="bib53">Man et al., 2015</xref>; <xref ref-type="bibr" rid="bib98">Zikich et al., 2008</xref>), secretion could be potentiated further with phorbolester (<xref ref-type="fig" rid="fig3">Figure 3</xref>). However, phorbolester was inhibitory in cells not expressing Syt7 (<xref ref-type="fig" rid="fig7">Figure 7</xref>). The inhibitory effect depended upon the overexpression of ubMunc13-2, as it was not found in non-overexpressing <italic>Syt7</italic> KO cells (<xref ref-type="bibr" rid="bib88">Tawfik et al., 2021</xref>); indeed, the reduction in secretion by application of PMA brings secretion back to approximately the level in <italic>Syt7</italic> KO cells not overexpressing ubMunc13-2 (<xref ref-type="bibr" rid="bib88">Tawfik et al., 2021</xref>), which indicates that it is the increase in secretion by ubMunc13-2 overexpression which is reversed by PMA in this case. Overall, an interaction between Syt7, ubMunc13-2 and DAG/phorbolester ensures optimal vesicle priming. We previously showed that although phorbolester was ineffective in the absence of Syt7 at low prestimulation [Ca<sup>2+</sup>], at higher prestimulation [Ca<sup>2+</sup>] it regained some potency (<xref ref-type="bibr" rid="bib88">Tawfik et al., 2021</xref>); therefore, in the absence of Syt7 other Ca<sup>2+</sup>-sensors can substitute in the stimulatory ‘triad’, most likely Syt1 or Doc2B (<xref ref-type="bibr" rid="bib28">Houy et al., 2017</xref>).</p><p>We could not detect any effect of Syt7 on Ca<sup>2+</sup>-dependent ubMunc13-2 trafficking, which likely is driven by Ca<sup>2+</sup>-binding to the ubMunc13-2 C2B-domain, or any direct binding in co-immunoprecipitation experiments. Instead, we suggest that the interaction is functional, and a likely explanation is the observation that in the <italic>Syt7</italic> KO, vesicles accumulate at 20–40 nm distance to the plasma membrane (<xref ref-type="bibr" rid="bib88">Tawfik et al., 2021</xref>). This distance is out of range of the rod-shaped elongated structure formed by Munc13 proteins (<xref ref-type="bibr" rid="bib69">Quade et al., 2019</xref>; <xref ref-type="bibr" rid="bib96">Xu et al., 2017</xref>). Recruitment of ubMunc13-2 to the plasma membrane in the absence of Syt7 will therefore not lead to productive bridging of vesicular and plasma membrane, and vesicle priming. Instead, the recruited ubMunc13-2 might inhibit release, by steric hindrance, by adopting an orientation that will not promote membrane bridging (<xref ref-type="bibr" rid="bib16">Camacho et al., 2021</xref>; <xref ref-type="bibr" rid="bib26">Grushin et al., 2022</xref>), or by covering up PIP<sub>2</sub>-patches in the plasma membrane, which are necessary for vesicle priming and fusion (<xref ref-type="bibr" rid="bib3">Aoyagi et al., 2005</xref>; <xref ref-type="bibr" rid="bib30">James et al., 2008</xref>; <xref ref-type="bibr" rid="bib57">Milosevic et al., 2005</xref>).</p><p>Even though phorbolester became inhibitory when Munc13-1 dominated, expression of Munc13-1 did increase secretion in the absence of phorbolester. Munc13-1 is therefore able to stimulate priming or fusion of DVs. Another difference between Munc13-1-EGFP and ubMunc13-2-EGFP was the ability of the latter to traffic to the membrane in parallel with the sustained part of the capacitance trace following an abrupt Ca<sup>2+</sup> increase. This indicates that ubMunc13-2 recruitment to the plasma membrane might be rate limiting for vesicle priming during sustained secretion. We did not see strong Ca<sup>2+</sup>-dependent recruitment of Munc13-1-EGFP to the membrane (over the course of ~5 s; note that it could recruit over longer times). Phorbolester recruited Munc13-1 to the plasma membrane, but caused inhibition of secretion. Together, these findings suggest that Munc13-1 might not act at the plasma membrane in priming of DVs. Another indication for an action at the vesicular level is the previous observation that the positive effect of Munc13-1-EGFP expression depends on the expression of CAPS proteins, and in CAPS-1/2 DKO chromaffin cells overexpression of Munc13-1-EGFP inhibited secretion (<xref ref-type="bibr" rid="bib47">Liu et al., 2010</xref>). CAPS is a vesicle-associated protein (<xref ref-type="bibr" rid="bib2">Ann et al., 1997</xref>; <xref ref-type="bibr" rid="bib35">Kabachinski et al., 2016</xref>), which contains a SNARE-binding MUN-domain (as Munc13s) and a PIP2-binding PH domain. The PH-domain is essential for its action in vesicle exocytosis (<xref ref-type="bibr" rid="bib25">Grishanin et al., 2004</xref>; <xref ref-type="bibr" rid="bib31">James et al., 2010</xref>; <xref ref-type="bibr" rid="bib62">Nguyen Truong et al., 2014</xref>), as it directs vesicles to dock and prime at PIP<sub>2</sub>-sites on the plasma membrane (<xref ref-type="bibr" rid="bib35">Kabachinski et al., 2016</xref>). CAPS and Munc13 proteins do not cross-rescue (<xref ref-type="bibr" rid="bib32">Jockusch et al., 2007</xref>; <xref ref-type="bibr" rid="bib34">Kabachinski et al., 2014</xref>), but ubMunc13-2 can overcome the need for CAPS when DAG is abundant, due to binding to ubMunc13-2’s C1-domain (<xref ref-type="bibr" rid="bib34">Kabachinski et al., 2014</xref>). This effect is likely related to the stimulatory effect of phorbolester in the presence of ubMunc13-2 that we identified here.</p><p>The negative effect of Munc13-1 in the presence of phorbolester could be caused by recruitment of Munc13-1 to the plasma membrane, which takes it away from its CAPS-dependent role, or it could be caused by the displacement of ubMunc13-2 at the plasma membrane. Both effects are apparently involved, since expression of Munc13-1-EGFP in the presence of endogenous ubMunc13-2 inhibited the burst (<xref ref-type="fig" rid="fig4">Figure 4</xref>), which was not the case when Munc13-1-EGFP was expressed in <italic>Unc13b</italic> KO cells (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Nevertheless, the data also indicate that there is a negative effect of PMA x Munc13-1, which is independent of Munc13-2.</p><p>Our data seem at odds with previous finding that expressing the Munc13-1 DAG-insensitive H567K mutant attenuated the effect of histamine in bovine chromaffin cells (<xref ref-type="bibr" rid="bib10">Bauer et al., 2007</xref>). Histamine acts on G<sub>q</sub>-coupled H1-receptors to increase DAG levels in chromaffin cells. However, the observations are probably consistent, because overexpressing the Munc13-1 H567K-mutation might overwhelm endogenous ubMunc13-2. Indeed, upon overexpression of Munc13-1 H567K, phorbolester was without effect (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>).</p><p>Given the very similar domain structure of Munc13-1 and ubMunc13-2, it is surprising to find different functions of the two proteins in DV fusion. However, it has already been reported that the C1-C2-MUN domain of Munc13-1 stimulates SV fusion, but not DV fusion in an in vitro assay (<xref ref-type="bibr" rid="bib39">Kreutzberger et al., 2017</xref>; <xref ref-type="bibr" rid="bib40">Kreutzberger et al., 2019</xref>). Several possibilities might explain these findings. Munc13-1 is a slightly longer protein that harbors an additional stretch of amino acids with unknown function immediately N-terminal of the CaM-binding site (<xref ref-type="bibr" rid="bib44">Lipstein et al., 2012</xref>). This stretch might confer preferential interaction with SVs over DVs, or it might interact with the membrane. Another possibility is that there might be subtle differences in the length, shape or angle with the PM of the rod-like domain in Munc13-1 and ubMunc13-2, which bridges vesicular and plasma membrane (<xref ref-type="bibr" rid="bib65">Padmanarayana et al., 2021</xref>; <xref ref-type="bibr" rid="bib69">Quade et al., 2019</xref>; <xref ref-type="bibr" rid="bib96">Xu et al., 2017</xref>). Strikingly, there is evidence that Munc13-1 can adopt different angles on the plasma membrane (<xref ref-type="bibr" rid="bib26">Grushin et al., 2022</xref>) and that the predominant angle changes upon binding to DAG via its C1-domain (<xref ref-type="bibr" rid="bib16">Camacho et al., 2021</xref>). For priming to occur, the angle might need to accurately fit the curvature of the vesicle, which is markedly different for SVs and DVs. A difference in the angle formed by DAG-bound Munc13-1 and ubMunc13-2 could confer preferential function towards SVs or DVs, respectively. A difference in the ability to oligomerize between vesicular membrane and PM might also be involved (<xref ref-type="bibr" rid="bib26">Grushin et al., 2022</xref>). However, until now comparative structural studies of ubMunc13-2 and Munc13-1 that could help solve this question are missing.</p><p>Overall, we found two striking differences between Munc13-1 and ubMunc13-2 in chromaffin cells: only ubMunc13-2 traffics to the plasma membrane with a time course matching secretion after an [Ca<sup>2+</sup>] increase, and only ubMunc13-2 supports more secretion in the presence of phorbolester. The latter effect depends on endogenous Syt7 expression, indicating that Munc13-2, Syt7 and DAG/phorbolesters form a stimulatory triad for DV fusion. As a consequence of the inability of Munc13-1 to substitute for ubMunc13-2 action, the ubMunc13-2/Munc13-1 ratio might determine the effect of DAG/phorbolesters/ in chromaffin cells.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">CD1</td><td align="left" valign="bottom">Experimental Medicine, Panum Stable, University of Copenhagen.</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Synaptotagmin-7</italic> (<italic>Syt7</italic>) null allele</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib55">Maximov et al., 2008</xref></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/18308933/">18308933</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Unc13a</italic> null allele</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib6">Augustin et al., 1999a</xref></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10440375/">10440375</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Unc13b</italic> null allele</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib91">Varoqueaux et al., 2005</xref></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/12070347/">12070347</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>Rattus Norvegicus</italic>)</td><td align="left" valign="bottom">pSFV1-ubmunc13-2-EGFP</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib98">Zikich et al., 2008</xref></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/18287511/">18287511</ext-link><break/>Local identifier: 486</td><td align="left" valign="bottom">Gift from Sonja Wojcik</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>Rattus Norvegicus</italic>)</td><td align="left" valign="bottom">pSFV1-ubmunc13-1-EGFP</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib4">Ashery et al., 1999</xref></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10494858/">10494858</ext-link><break/>Local identifier: 487</td><td align="left" valign="bottom">Gift from Sonja Wojcik</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-Chromogranin A (Rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Ab15160<break/>RRID:<break/><ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_301704">AB_301704</ext-link></td><td align="left" valign="bottom">1:500; Overnight at 4 degrees</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-TH (Mouse monoclonal)</td><td align="left" valign="bottom">Merck Millipore</td><td align="left" valign="bottom">MAB318<break/>RRID:<break/><ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2201528">AB_2201528</ext-link></td><td align="left" valign="bottom">1:2000; Overnight at 4 degrees</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-Synaptotagmin-7 (Rabbit polyclonal)</td><td align="left" valign="bottom">Synaptic System</td><td align="left" valign="bottom">SYSY: 105173<break/>RRID:<break/><ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_887838">AB_887838</ext-link></td><td align="left" valign="bottom">1:500; Overnight at 4 degrees.</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Munc13-1 (mouse monoclonal)</td><td align="left" valign="bottom">Home-made (Max Planck Institute of Multidisciplinary Sciences, Göttingen) <xref ref-type="bibr" rid="bib11">Betz et al., 1998</xref></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/9697857/">9697857</ext-link></td><td align="left" valign="bottom">1:1000<break/>1 hr at room temperature</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Munc13-1 (Rabbit polyclonal)</td><td align="left" valign="bottom">Home-made (Max Planck Institute of Multidisciplinary Sciences, Göttingen) <xref ref-type="bibr" rid="bib91">Varoqueaux et al., 2005</xref></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/15988013">15988013</ext-link></td><td align="left" valign="bottom">Co-IP: 1:300<break/>1 hr at 4 degrees</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-bMunc13 (Rabbit polyclonal)</td><td align="left" valign="bottom">Synaptic System</td><td align="left" valign="bottom">SYSY126203<break/>RRID:<break/><ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2619807">AB_2619807</ext-link></td><td align="left" valign="bottom">1:1000; Overnight at 4 degrees</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-β-Actin−Peroxidase antibody (Mouse monoclonal)</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">A3854<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_262011">AB_262011</ext-link></td><td align="left" valign="bottom">1:10000; 30 min at room temperature</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-rabbit HRP (Goat polyclonal)</td><td align="left" valign="bottom">Agilent</td><td align="left" valign="bottom">Dako-P0448<break/>RRID:<break/><ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2617138">AB_2617138</ext-link></td><td align="left" valign="bottom">1:2000; 1 hr and 30 min at room temperature</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-rabbit Alexa 488 (Goat polyclonal)</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">A11008<break/>RRID:<break/><ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_143165">AB_143165</ext-link></td><td align="left" valign="bottom">1:500; 30 min at room temperature</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-mouse Alexa 647 (Goat polyclonal)</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">A21235<break/>RRID:<break/><ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535804">AB_2535804</ext-link></td><td align="left" valign="bottom">1:500; 30 min at room temperature</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-GFP (Rabbit polyclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">SYSY132003<break/>RRID:<break/><ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1834147">AB_1834147</ext-link></td><td align="left" valign="bottom">1:300; Overnight at 4 degrees</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">BCA Protein assay kit</td><td align="left" valign="bottom">Pierce</td><td align="left" valign="bottom">Pierce: 23227</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">GFP-Trap</td><td align="left" valign="bottom">Chromotek</td><td align="left" valign="bottom">gtak-20</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">NaCl</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: S9888</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">KCl</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: P5405</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">NaH2PO4</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: S8282</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Glucose</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: G8270</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DMEM</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Gibco: 31966047</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">L-cysteine</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: C7352</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">CaCl2</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: 499609</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">EDTA</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: E5134</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">papain</td><td align="left" valign="bottom">Worthington Biochemical</td><td align="left" valign="bottom">Worthington Biochemical: LS003126</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">albumin</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: A3095</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">trypsin-inhibitor</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: T9253</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">penicillin/ streptomycin</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Invitrogen: 15140122</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">insulin-transferrin-selenium-X</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Invitrogen: 51500056</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">fetal calf serum</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Invitrogen: 10500064</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">MgCl2</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: 449172</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">HEPES</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: H3375</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Nitrophenyl-EGTA (NPE)</td><td align="left" valign="bottom">Synthesized at the Max-Planck-Institute for biophysical chemistry, Göttingen.</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Fura-4F</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Invitrogen: F14174</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Furaptra</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Invitrogen: M1290</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Mg-ATP</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: A9187</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">GTP</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: G8877</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Vitamin C</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: A5960</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">EGTA</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: E4378</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Paraformaldehyde</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: P6148</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">PIPES</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: 80635</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Triton X-100</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: T8787</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">BSA</td><td align="left" valign="bottom">Sigma-aldrich</td><td align="left" valign="bottom">Sigma-aldrich: A4503</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Prolong Gold</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Invitrogen: P36934</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Protease cocktail inhibitor</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Invitrogen: 87785</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">RIPA buffer</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Invitrogen: R0278</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">ECL plus western blotting substrate</td><td align="left" valign="bottom">Pierce</td><td align="left" valign="bottom">Pierce: 32132</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Go 6983</td><td align="left" valign="bottom">Tocris</td><td align="left" valign="bottom">Tocris:133053-19-7<break/>PubChem ID:<break/>3499</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Igor</td><td align="left" valign="bottom">wavemetrics</td><td align="left" valign="bottom">Versions 6.2.1.0 and 8.0.4.2</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ</td><td align="left" valign="bottom">NIH software</td><td align="left" valign="bottom">Version 1.53e</td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mouse lines and cell culture</title><p>Mouse lines, C57/Bl6 <italic>Unc13a</italic> (<xref ref-type="bibr" rid="bib7">Augustin et al., 1999b</xref>), C57/Bl6 <italic>Unc13b</italic> (<xref ref-type="bibr" rid="bib90">Varoqueaux et al., 2002</xref>), C57/Bl6 <italic>Syt7</italic> (<xref ref-type="bibr" rid="bib55">Maximov et al., 2008</xref>), were kept in an AAALAC-accredited stable at the University of Copenhagen operating a 12 hr/12 hr light/dark cycle with access to water and food ad libitum. Permission to keep and breed KO mice was obtained from the Danish Animal Experiments Inspectorate (permission 2018-15-0202-00157). <italic>Unc13b</italic> and <italic>Syt7</italic> knockout (KO) and WT cells were obtained from P0-P2 pups of either sex originating from heterozygous crossing and identified by PCR genotyping. Because <italic>Unc13a</italic> KO animals die within a few hours of birth (<xref ref-type="bibr" rid="bib7">Augustin et al., 1999b</xref>), we obtained <italic>Unc13a</italic> cells from embryos of either sex at embryonic day 18 (E18) from crosses of <italic>Unc13a</italic> heterozygous (+/-) mice<italic>. Unc13a</italic> KO and WT animals were identified by PCR genotyping. Some of the experiments made use of wild-type chromaffin cells from a CD1 outbred mouse strain. Note that <italic>Unc13a</italic> WT, <italic>Unc13b</italic> WT, <italic>Syt7</italic> WT and CD1 WT cells are all wild type, but originate from different mouse lines. Comparison of a KO was always made to WT littermates. Adrenal chromaffin cells primary culture was described previously (<xref ref-type="bibr" rid="bib29">Houy et al., 2021</xref>; <xref ref-type="bibr" rid="bib83">Sørensen et al., 2003</xref>; <xref ref-type="bibr" rid="bib88">Tawfik et al., 2021</xref>). Briefly, the adrenal glands were dissected out and cleaned in Locke’s solution (mM: 154 NaCl, 5.6 KCl, 0.85 NaH<sub>2</sub>PO<sub>4</sub>, 2.15 Na<sub>2</sub>HPO<sub>4</sub>, and 10 glucose; and adjusted to pH 7.0). The glands were digested with papain enzyme (20–25 units/ml) for 45 min at 37 °C and 8% CO<sub>2</sub> followed by 10–15 min inactivation with DMEM-Inactivation solution. Cells were dissociated and plated in a drop of medium on glass coverslips for 30–45 min, and finally supplemented with 1–2 ml of enriched DMEM media. Cells were used 2–5 days after plating.</p></sec><sec id="s4-2"><title>Viral constructs</title><p>Acute expression of EGFP-fused ubMunc13-2, Munc13-1 or Munc13-1 H567K was induced by infection with Semliki Forest Virus constructs (<xref ref-type="bibr" rid="bib5">Ashery et al., 2000</xref>; <xref ref-type="bibr" rid="bib98">Zikich et al., 2008</xref>). The constructs (a gift from Nils Brose and Sonja Wojcik, Göttingen) were verified by sequencing with a specific set of primers for each construct. For Munc13-1-EGFP and Munc13-1 H567K-EGFP, the following primers were used; 5´-ATC <named-content content-type="sequence">CCAATTCGGCACGAGC</named-content>-3´; 5´-<named-content content-type="sequence">CCG CCT TAC TAC ACG ACT TC</named-content>-3´; 5´-<named-content content-type="sequence">CAC CTG AAG AGA AGG CAG CT</named-content>-3´; 5´-<named-content content-type="sequence">GCC TGA GAT CTT CGA GCT G</named-content>-3´; 5´-<named-content content-type="sequence">CGA CGC CTG GAA GGT TTA C</named-content>-3´; 5´-<named-content content-type="sequence">TCC TAC ACA CCC TGC CTC</named-content> A-3´; 5´-<named-content content-type="sequence">GAA CCC TGA AGG AGC TGC A</named-content>-3´; 5´-<named-content content-type="sequence">CCA CCG ACC TGC TCA TCA AA</named-content>-3´; 5´-<named-content content-type="sequence">TCA AGT CCG ACA CGC GCT</named-content>-3´; 5´-<named-content content-type="sequence">TCA ATT AAT TAC CCG GCC GC</named-content>-3´; 5´-<named-content content-type="sequence">CGC ATT TAC GGC GCT GAT GA</named-content>-3´. The resulting sequences differ from the primary source sequence available at the Rat Genome Database (RGD ID: 619722) by two substitutions, L756W and E1666G. These two apparent substitutions are likely caused by sequencing errors in the original constructs (<xref ref-type="bibr" rid="bib14">Brose et al., 1995</xref>), since the residues are W and G, respectively, in the Munc13-2 and Munc13-3 published in the same paper, and in <italic>C. elegans unc-13</italic> (<xref ref-type="bibr" rid="bib54">Maruyama and Brenner, 1991</xref>)(Nils Brose, personal communication). The construct furthermore contains two deletions of 23 and 19 amino acids, which correspond to alternatively spliced exons (<xref ref-type="bibr" rid="bib14">Brose et al., 1995</xref>). All previous work is based on Munc13-1 versions lacking these exons (Nils Brose, personal communication).</p><p>The following primers were used to sequence Munc13-2-EGFP: 5´-<named-content content-type="sequence">ACA CCT CTA CGG CGG TCC TAG</named-content>-3´; 5´-<named-content content-type="sequence">GAA AGC CAG AGG AAG CTG TT</named-content>-3´; 5´<named-content content-type="sequence">AGG TGA ATC CAA GGA GAG AGA T</named-content>-3´; 5´-<named-content content-type="sequence">AGA CCT GCT CAA TGC CGA TTG</named-content>-3´; 5´-<named-content content-type="sequence">AGG GGC TAT CCG ACT GCA AAT</named-content>-3´; 5´-<named-content content-type="sequence">AGG GGC TAT CCG ACT GCA A</named-content>-3´; 5´-<named-content content-type="sequence">ACA GTG GAC TTG CTG ACC AG</named-content>-3´; 5´-<named-content content-type="sequence">GAC GTG TCC CTG GAA TTC CT</named-content>-3´; 5´-<named-content content-type="sequence">GAT TTC CTG GAT GGC AAC CTC</named-content>-3´; 5´-<named-content content-type="sequence">CTG GCA CTG GGG AGC ATA A</named-content>-3´; 5´-<named-content content-type="sequence">AGT GGC CTG CAA CGG CCA AGG AC</named-content>-3´. The obtained sequencing results were in alignment with the primary source sequence available at the Rat Genome Database (RGD ID: 619723).</p><p>Semliki Forest Virus particles were produced as previously described (<xref ref-type="bibr" rid="bib4">Ashery et al., 1999</xref>), and activated using chymotrypsin for 45 min, following by inactivation with aprotinin. Measurements were carried out 12–17 hr after transfection of chromaffin cells.</p></sec><sec id="s4-3"><title>Immunostaining and confocal microscopy</title><p>Cells were plated on 25 mg/ml poly-D-lysine (Sigma P7405) coated coverslips and fixated with 4% Paraformaldehyde (PFA; EMC 15710) and 0.2% Glutaraldehyde (Merck Millipore 104239) for 15 min at room temperature (RT), followed by 2% PFA for an additional 10 min at room temperature (RT). Cells were permeabilized with 0.15% Triton-X100 (Sigma-Aldrich T8787) for 15 min at RT and subsequently blocked with 0.2% cold fish gelatin (Sigma-Aldrich G7765), 1% goat serum (Thermo Fisher Scientific 16210064) and 3% Bovine Albumin Serum (Sigma-Aldrich A4503) for 1 hr at RT. Cells were washed with PBS and glutaraldehyde autofluorescence was quenched with 0.1% Sodium Borohydride (NaBH4; Sigma-Aldrich 213462). Primary antibodies were diluted in blocking solution and incubated as follow: rabbit polyclonal α-CgA (1:500; Abcam 15160) and mouse monoclonal α-TH (1:2000; Merck Millipore MAB318) overnight at 4 °C. Secondary antibodies used were goat α-rabbit Alexa Fluor 488 conjugate (1:500, Abcam ab150169), goat α-mouse Alexa Fluor 647 conjugate (1:500, Thermo Fisher Scientific A21235). Immunofluorescence was visualized using a Zeiss LSM 780 inverted confocal with oil-immersion Plan-Apochromat NA 1.4 63 x objective. The fluorophores were excited with Argon 488 nm (25 mW) and HeNe 633 nm (5 mW) lasers. For each cell, an image stack was obtained, and quantification of CgA was performed using ImageJ software (version 1.53e) on the image plane where the diameter of the cell was largest. Integrated densities of ROIs manually drawn around the entire cell (Total intensity) or excluding the rim of the cell (Inside intensity) were background subtracted. The Total intensity divided by the Inside intensity was used as a measure for plasma membrane localization (<xref ref-type="fig" rid="fig1">Figure 1O</xref>). <italic>Unc13b</italic> WT and KO cells were acquired on the same day, and laser power, gain and emission detection were unchanged.</p></sec><sec id="s4-4"><title>Western blot</title><p>Extracts from HEK293FT cells expressing ubMunc13-2-EGFP or Munc13-1-EGFP, as well as non-expressing cells, were collected and lysed in RIPA buffer supplemented with Protease Inhibitor Cocktail (Invitrogen, 89900). The supernatants were collected and protein concentrations were estimated using the BCA Protein Assay Kit (Pierce 23227) after plotting the resulting BSA curve. 25 mg of protein was resolved by 4–12% SDS-PAGE (Invitrogen, Thermo Fisher Scientific) and wet-transferred onto an Amersham Hybond LFP PVDF membrane (GE Healthcare). The membrane was blotted with rabbit polyclonal α-GFP (1:300; Synaptic Systems SY132003) and HRP-conjugated mouse monoclonal α-β-Actin-Peroxidase (1:10000; Sigma-Aldrich A3854), as a loading control, followed by HRP-conjugated α-rabbit (1:2000; Agilent Dako-P0448) secondary antibody. The blot was developed by chemiluminescence Pierce ECL Plus Western blotting substrate systems (Thermofisher Scientific) and immunoreactive bands were detected using the FluorChemE image acquisition system (ProteinSimple) equipped with a cooled CCD camera.</p></sec><sec id="s4-5"><title>Immunoprecipitation experiments</title><p>Immunoprecipitation of Munc13-2: Brain tissue from the Munc13-2-EYFP knockin mouse (<xref ref-type="bibr" rid="bib19">Cooper et al., 2012</xref>) (a gift from Nils Brose, Max-Planck Institute for experimental medicine, Göttingen) was lysed and homogenized in 10 mM Tris/Cl pH 7.5; 150 mM NaCl; 0.5 mM EDTA; 0.5% NP-40 lysis buffer supplemented with Protease Inhibitor Cocktail (Invitrogen, 89900), with the aid of an homogenizer. Pairs of samples of protein extracts used in the immunoprecipitation (input), supernatant (non-bound) and eluted supernatant were obtained by the protocol provided by GFP-Trap_A Chromotek. One of the samples from each pair was incubated with 1 mM Ca<sup>2+</sup>. Samples were resolved by 4–12% SDS-PAGE (Invitrogen, Thermofisher Scientific) and wet-transferred onto an Amershan Hybond LFP PVDF membrane (GE Healthcare). The membrane was blotted with rabbit polyclonal α-Syt7 (1:500; Synaptic Systems SY105173) and rabbit polyclonal α-bMunc13-2 (1:1000; Synaptic Systems SY126203), followed by HRP-conjugated α-rabbit (1:2000; Agilent Dako-P0448) secondary antibody. The blot was revealed by chemiluminescence Pierce ECL Plus Western blotting substrate system (Thermofisher Scientific) and the bands detected using the FluorChemE image acquisition system (ProteinSimple) equipped with a cooled CCD camera.</p><p>Immunoprecipitation of Munc13-1: Cerebral corti of adult (8–11 weeks) WT mice were used to prepare a P2 synaptosomal fraction. The fraction was solubilized in a buffer containing 50 mM Tris/HCl pH 8, 150 mM NaCl, 1 mM CaCl2, 1 mM EGTA, 1% IGEPAL, 0.2 mM phenylmethylsulfonyl fluoride, 1 mg/ml aprotinin, and 0.5 mg/ml leupeptin (solubilization buffer), to a final protein concentration of 2 mg/ml, and ultracentrifuged at 100,000 g to remove insoluble material. A sample (‘input’) was collected, and the remaining fraction was incubated for 1 hr with a home-made mouse monoclonal-anti-Munc13-1 antibody (3H5 <xref ref-type="bibr" rid="bib11">Betz et al., 1998</xref>) in solubilization buffer. Next, Sepharose-Protein G beads (Invitrogen) were added to capture the antibody and associated proteins, and incubated in rotation for 1 hr. The samples were washed five times with solubilization buffer containing 0.1% IGEPAL to remove background, and eluted using denaturating Laemmli buffer (‘IP’ samples). Western blot analysis was performed on 4–12% gradient Bis-Tris polyacrylamide gels (Invitrogen) using a home-made rabbit polyclonal antibody against Munc13-1 (<xref ref-type="bibr" rid="bib91">Varoqueaux et al., 2005</xref>) and a rabbit polyclonal antibody (105 173, Synaptic Systems) against Syt7.</p></sec><sec id="s4-6"><title>Electrophysiology</title><p>Two different electrophysiological setups have been used in this study: 1. The first one combining capacitance measurements, carbon-fiber amperometry, calcium uncaging and calcium concentration detection (Setup 1, used for <xref ref-type="fig" rid="fig1">Figures 1</xref> and <xref ref-type="fig" rid="fig2">2</xref>, and <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>), and 2. the second one combining capacitance measurement, calcium uncaging and GFP imaging (Setup 2; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>, used for all other data).</p><p>In setup 1, exocytosis was monitored by combining membrane capacitance measurements and carbon fibre amperometry (<xref ref-type="bibr" rid="bib29">Houy et al., 2021</xref>). Capacitance measurements were based on the Lindau-Neher technique using Pulse HEKA software with Lock-In extension. A 70 mV peak-to-peak sinusoid (1000 Hz) was applied around a holding potential of –70 mV in the whole-cell configuration. The clamp currents were filtered at 3 kHz and recorded at 12 kHz with an EPC9 HEKA amplifier. Secretion was triggered by 1–2ms UV flash-photolysis of the caged Ca<sup>2+</sup> compound nitrophenyl-EGTA, infused through the patch pipette. The UV-flash delivered from a flash lamp (Rapp Optoelectronic, JML-C2) was bandpass-filtered around 395 nm, transmitted through a light guide and a dual condenser and focused with a Fluor 40 X/N.A. 1.30 oil objective.</p><p>The intracellular Ca<sup>2+</sup> concentration was determined as described in <xref ref-type="bibr" rid="bib59">Nagy et al., 2002</xref>. Two florescent dyes with different affinities toward Ca<sup>2+</sup>, Fura4F (Kd = 1 µM) and furaptra (Kd = 40 µM) were infused via the pipette into the cell. For ratiometric detection, alternating monochromator excitations of 350 nm and 380 nm were generated at 40 Hz and emission was detected via a photodiode, recorded at 3 kHz and filtered at 12 kHz. The 350/380 ratio was pre-calibrated by infusing the cell with known Ca<sup>2+</sup> concentrations. Amperometric recordings were performed as previously described (<xref ref-type="bibr" rid="bib15">Bruns, 2004</xref>) using a carbon fibre (5–10 µm diameter) insulated with polyethylene and mounted in glass pipette. The fibre was clamped at +700 mV, currents were filtered at 5 kHz and sampled at 25 kHz by an EPC7 HEKA amplifier. Kinetic analysis was performed with Igor Pro software (Wavemetrics – Version 8.04) using a semi-automatic procedure, as previously described (<xref ref-type="bibr" rid="bib88">Tawfik et al., 2021</xref>).</p><p>For capacitance measurements in conjunction with EGFP-imaging (setup 2), capacitance measurements and calcium-uncaging were performed with the same method as described above and data were processed in Igor Pro software (Wavemetrics – version 6.21). Burst secretion (approximately corresponding to the sum of the RRP and SRP sizes) was measured at 0.5 s after the flash and the sustained release was obtained by subtracting the total release (capacitance amplitude 5 s after the flash) by the amplitude of the burst. For GFP imaging, image acquisition was performed using a CCD camera (SensiCam, pco.imaging). The protocol of picture acquisitions was the following: 3 pictures in resting condition (202ms interval- 200ms exposure time) followed by the UV-flash photolysis of caged calcium (100ms after the last Resting picture), followed by the acquisition of 20 pictures every 502ms and starting 369ms after the UV flash.</p><p>Quantification of the GFP signal was performed in ImageJ software (version 1.53e). Integrated densities of ROIs manually drawn around the entire cell (Total intensity) or excluding the rim of the cell (Inside intensity) were background subtracted. The Total intensity divided by the Inside intensity was used as a measure for plasma membrane localization. Data from all conditions were collected in parallel, using the same culture(s) on the same day(s).</p><p>To characterize the PMA-induced recruitment kinetic of Munc13 proteins, 100 nM PMA was added on mouse adrenal chromaffin cells (setup 2) expressing either ubMunc13-2-EGFP, Munc13-1-EGFP or Munc13-1-H567K-EGFP. For GFP-imaging, the image acquisition protocol was the following: 1 picture every 30 s from 30 s to 8 min after adding the PMA followed by 1 picture per min from 8 to 12 min.</p><p>The pipette solution contained (in mM): 100 Cs-glutamate, 8 NaCl, 4 CaCl<sub>2</sub>, 32 Cs-HEPES, 2 Mg-ATP, 0.3 GTP, 5 NPE, 0.4 fura-4F, 0.4 furaptra, and 1 vitamin C. Adjusted to pH 7.2 and osmolarity to 295 mOsm. The extracellular solution contained (in mM): 145 NaCl, 2.8 KCl, 2 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 10 HEPES, and 11 glucose. Adjusted to pH 7.2 and osmolarity to 305 mOsm. Phorbol 12-myristate 13-acetate (PMA) (Sigma P8139) and the PKC inhibitor Gö6983 (Tocris 2285) were dissolved in DMSO and diluted in extracellular solution immediately prior to the experiment, to a final concentration of 100 nM and 500 nM, respectively, and used within an hour.</p></sec><sec id="s4-7"><title>Statistics</title><p>The data are presented as mean and SEM in the text; median values are given in the source data files; n indicates the number of cells and N the number of cell preparations. The parameters estimated here sometimes fulfills the requirements for parametric testing, and sometimes not. To ensure a uniform method of statistical testing, we used non-parametric tests, unless otherwise noted. Non-parametric Mann-Whitney test was used to test changes between two experimental groups, whereas Kruskal-Wallis with post Dunn’s test were applied when more than two groups were compared.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Formal analysis, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Supervision, Funding acquisition, Writing - original draft, Project administration</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-79433-mdarchecklist1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generates or analysed during this study are included in the manuscript and supporting files; the source data files contain the numerical data used to generate the figures.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Dorte Lauritsen for excellent technical assistance, including genotyping of animals. This investigation was supported by the Novo Nordic Foundation (NNF19OC0058298, JBS), the Independent Research Fund Denmark (0134–00141 A, JBS), the Lundbeck Foundation (R277-2018-802, JBS) and the Deutsche Forschungsgemeinschaft (German Research Foundation, DFG; EXC-2049–390688087 and SFB1286/A11, NL). We are thankful to Nils Brose and Sonja Wojcik, Max-Planck-Institute for Multidisciplinary Sciences, Göttingen, for providing knockout mice, EGFP-fused Munc13-1, Munc13-1 H567K and ubMunc13-2 SFV plasmids, and brain tissue from the EYFP-Munc13-2 mouse.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Álvarez de Toledo</surname><given-names>G</given-names></name><name><surname>Montes</surname><given-names>MÁ</given-names></name><name><surname>Montenegro</surname><given-names>P</given-names></name><name><surname>Borges</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Phases of the exocytotic fusion pore</article-title><source>FEBS Letters</source><volume>592</volume><fpage>3532</fpage><lpage>3541</lpage><pub-id pub-id-type="doi">10.1002/1873-3468.13234</pub-id><pub-id pub-id-type="pmid">30169901</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ann</surname><given-names>K</given-names></name><name><surname>Kowalchyk</surname><given-names>JA</given-names></name><name><surname>Loyet</surname><given-names>KM</given-names></name><name><surname>Martin</surname><given-names>TF</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Novel Ca2+-binding protein (CAPS) related to UNC-31 required for Ca2+-activated exocytosis</article-title><source>The Journal of Biological Chemistry</source><volume>272</volume><fpage>19637</fpage><lpage>19640</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.32.19637</pub-id><pub-id pub-id-type="pmid">9289490</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoyagi</surname><given-names>K</given-names></name><name><surname>Sugaya</surname><given-names>T</given-names></name><name><surname>Umeda</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Terakawa</surname><given-names>S</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The activation of exocytotic sites by the formation of phosphatidylinositol 4,5-bisphosphate microdomains at syntaxin clusters</article-title><source>The Journal of Biological Chemistry</source><volume>280</volume><fpage>17346</fpage><lpage>17352</lpage><pub-id pub-id-type="doi">10.1074/jbc.M413307200</pub-id><pub-id pub-id-type="pmid">15741173</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashery</surname><given-names>U</given-names></name><name><surname>Betz</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Rettig</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>An efficient method for infection of adrenal chromaffin cells using the Semliki Forest virus gene expression system</article-title><source>European Journal of Cell Biology</source><volume>78</volume><fpage>525</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1016/s0171-9335(99)80017-x</pub-id><pub-id pub-id-type="pmid">10494858</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashery</surname><given-names>U</given-names></name><name><surname>Varoqueaux</surname><given-names>F</given-names></name><name><surname>Voets</surname><given-names>T</given-names></name><name><surname>Betz</surname><given-names>A</given-names></name><name><surname>Thakur</surname><given-names>P</given-names></name><name><surname>Koch</surname><given-names>H</given-names></name><name><surname>Neher</surname><given-names>E</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Rettig</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Munc13-1 acts as a priming factor for large dense-core vesicles in bovine chromaffin cells</article-title><source>The EMBO Journal</source><volume>19</volume><fpage>3586</fpage><lpage>3596</lpage><pub-id pub-id-type="doi">10.1093/emboj/19.14.3586</pub-id><pub-id pub-id-type="pmid">10899113</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Augustin</surname><given-names>I</given-names></name><name><surname>Betz</surname><given-names>A</given-names></name><name><surname>Herrmann</surname><given-names>C</given-names></name><name><surname>Jo</surname><given-names>T</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1999">1999a</year><article-title>Differential expression of two novel munc13 proteins in rat brain</article-title><source>The Biochemical Journal</source><volume>337 (Pt 3)</volume><fpage>363</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">9895278</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Augustin</surname><given-names>I</given-names></name><name><surname>Rosenmund</surname><given-names>C</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1999">1999b</year><article-title>Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles</article-title><source>Nature</source><volume>400</volume><fpage>457</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1038/22768</pub-id><pub-id pub-id-type="pmid">10440375</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bacaj</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Morishita</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Synaptotagmin-1 and synaptotagmin-7 trigger synchronous and asynchronous phases of neurotransmitter release</article-title><source>Neuron</source><volume>80</volume><fpage>947</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.10.026</pub-id><pub-id pub-id-type="pmid">24267651</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>RW</given-names></name><name><surname>Jeffrey</surname><given-names>PD</given-names></name><name><surname>Zick</surname><given-names>M</given-names></name><name><surname>Phillips</surname><given-names>BP</given-names></name><name><surname>Wickner</surname><given-names>WT</given-names></name><name><surname>Hughson</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A direct role for the sec1/munc18-family protein VPS33 as a template for SNARE assembly</article-title><source>Science</source><volume>349</volume><fpage>1111</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1126/science.aac7906</pub-id><pub-id pub-id-type="pmid">26339030</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>CS</given-names></name><name><surname>Woolley</surname><given-names>RJ</given-names></name><name><surname>Teschemacher</surname><given-names>AG</given-names></name><name><surname>Seward</surname><given-names>EP</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Potentiation of exocytosis by phospholipase C-coupled G-protein-coupled receptors requires the priming protein Munc13-1</article-title><source>The Journal of Neuroscience</source><volume>27</volume><fpage>212</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4201-06.2007</pub-id><pub-id pub-id-type="pmid">17202488</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betz</surname><given-names>A</given-names></name><name><surname>Ashery</surname><given-names>U</given-names></name><name><surname>Rickmann</surname><given-names>M</given-names></name><name><surname>Augustin</surname><given-names>I</given-names></name><name><surname>Neher</surname><given-names>E</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name><name><surname>Rettig</surname><given-names>J</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Munc13-1 is a presynaptic phorbol ester receptor that enhances neurotransmitter release</article-title><source>Neuron</source><volume>21</volume><fpage>123</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80520-6</pub-id><pub-id pub-id-type="pmid">9697857</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betz</surname><given-names>A</given-names></name><name><surname>Thakur</surname><given-names>P</given-names></name><name><surname>Junge</surname><given-names>HJ</given-names></name><name><surname>Ashery</surname><given-names>U</given-names></name><name><surname>Rhee</surname><given-names>JS</given-names></name><name><surname>Scheuss</surname><given-names>V</given-names></name><name><surname>Rosenmund</surname><given-names>C</given-names></name><name><surname>Rettig</surname><given-names>J</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Functional interaction of the active zone proteins munc13-1 and RIM1 in synaptic vesicle priming</article-title><source>Neuron</source><volume>30</volume><fpage>183</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(01)00272-0</pub-id><pub-id pub-id-type="pmid">11343654</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breustedt</surname><given-names>J</given-names></name><name><surname>Gundlfinger</surname><given-names>A</given-names></name><name><surname>Varoqueaux</surname><given-names>F</given-names></name><name><surname>Reim</surname><given-names>K</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Schmitz</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Munc13-2 differentially affects hippocampal synaptic transmission and plasticity</article-title><source>Cerebral Cortex</source><volume>20</volume><fpage>1109</fpage><lpage>1120</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhp170</pub-id><pub-id pub-id-type="pmid">19700493</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Hofmann</surname><given-names>K</given-names></name><name><surname>Hata</surname><given-names>Y</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Mammalian homologues of <italic>Caenorhabditis elegans</italic> unc-13 gene define novel family of C2-domain proteins</article-title><source>The Journal of Biological Chemistry</source><volume>270</volume><fpage>25273</fpage><lpage>25280</lpage><pub-id pub-id-type="doi">10.1074/jbc.270.42.25273</pub-id><pub-id pub-id-type="pmid">7559667</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruns</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Detection of transmitter release with carbon fiber electrodes</article-title><source>Methods</source><volume>33</volume><fpage>312</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2004.01.004</pub-id><pub-id pub-id-type="pmid">15183180</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camacho</surname><given-names>M</given-names></name><name><surname>Quade</surname><given-names>B</given-names></name><name><surname>Trimbuch</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Sari</surname><given-names>L</given-names></name><name><surname>Rizo</surname><given-names>J</given-names></name><name><surname>Rosenmund</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Control of neurotransmitter release by two distinct membrane-binding faces of the munc13-1 c1c2b region</article-title><source>eLife</source><volume>10</volume><elocation-id>72030</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.72030</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>CW</given-names></name><name><surname>Chiang</surname><given-names>CW</given-names></name><name><surname>Jackson</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Fusion pores and their control of neurotransmitter and hormone release</article-title><source>The Journal of General Physiology</source><volume>149</volume><fpage>301</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1085/jgp.201611724</pub-id><pub-id pub-id-type="pmid">28167663</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Cooper</surname><given-names>B</given-names></name><name><surname>Kalla</surname><given-names>S</given-names></name><name><surname>Varoqueaux</surname><given-names>F</given-names></name><name><surname>Young</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The munc13 proteins differentially regulate readily releasable pool dynamics and calcium-dependent recovery at a central synapse</article-title><source>The Journal of Neuroscience</source><volume>33</volume><fpage>8336</fpage><lpage>8351</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5128-12.2013</pub-id><pub-id pub-id-type="pmid">23658173</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>B</given-names></name><name><surname>Hemmerlein</surname><given-names>M</given-names></name><name><surname>Ammermüller</surname><given-names>J</given-names></name><name><surname>Imig</surname><given-names>C</given-names></name><name><surname>Reim</surname><given-names>K</given-names></name><name><surname>Lipstein</surname><given-names>N</given-names></name><name><surname>Kalla</surname><given-names>S</given-names></name><name><surname>Kawabe</surname><given-names>H</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Brandstätter</surname><given-names>JH</given-names></name><name><surname>Varoqueaux</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Munc13-independent vesicle priming at mouse photoreceptor ribbon synapses</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>8040</fpage><lpage>8052</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4240-11.2012</pub-id><pub-id pub-id-type="pmid">22674279</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Jong</surname><given-names>APH</given-names></name><name><surname>Meijer</surname><given-names>M</given-names></name><name><surname>Saarloos</surname><given-names>I</given-names></name><name><surname>Cornelisse</surname><given-names>LN</given-names></name><name><surname>Toonen</surname><given-names>RFG</given-names></name><name><surname>Sørensen</surname><given-names>JB</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Phosphorylation of synaptotagmin-1 controls a post-priming step in PKC-dependent presynaptic plasticity</article-title><source>PNAS</source><volume>113</volume><fpage>5095</fpage><lpage>5100</lpage><pub-id pub-id-type="doi">10.1073/pnas.1522927113</pub-id><pub-id pub-id-type="pmid">27091977</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dulubova</surname><given-names>I</given-names></name><name><surname>Sugita</surname><given-names>S</given-names></name><name><surname>Hill</surname><given-names>S</given-names></name><name><surname>Hosaka</surname><given-names>M</given-names></name><name><surname>Fernandez</surname><given-names>I</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name><name><surname>Rizo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>A conformational switch in syntaxin during exocytosis: role of Munc18</article-title><source>The EMBO Journal</source><volume>18</volume><fpage>4372</fpage><lpage>4382</lpage><pub-id pub-id-type="doi">10.1093/emboj/18.16.4372</pub-id><pub-id pub-id-type="pmid">10449403</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedrich</surname><given-names>R</given-names></name><name><surname>Gottfried</surname><given-names>I</given-names></name><name><surname>Ashery</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Munc13-1 translocates to the plasma membrane in a doc2b- and calcium-dependent manner</article-title><source>Frontiers in Endocrinology</source><volume>4</volume><elocation-id>119</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2013.00119</pub-id><pub-id pub-id-type="pmid">24062723</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulop</surname><given-names>T</given-names></name><name><surname>Smith</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Physiological stimulation regulates the exocytic mode through calcium activation of protein kinase C in mouse chromaffin cells</article-title><source>The Biochemical Journal</source><volume>399</volume><fpage>111</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1042/BJ20060654</pub-id><pub-id pub-id-type="pmid">16784416</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genc</surname><given-names>O</given-names></name><name><surname>Kochubey</surname><given-names>O</given-names></name><name><surname>Toonen</surname><given-names>RF</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name><name><surname>Schneggenburger</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Munc18-1 is a dynamically regulated PKC target during short-term enhancement of transmitter release</article-title><source>eLife</source><volume>3</volume><elocation-id>e01715</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.01715</pub-id><pub-id pub-id-type="pmid">24520164</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grishanin</surname><given-names>RN</given-names></name><name><surname>Kowalchyk</surname><given-names>JA</given-names></name><name><surname>Klenchin</surname><given-names>VA</given-names></name><name><surname>Ann</surname><given-names>K</given-names></name><name><surname>Earles</surname><given-names>CA</given-names></name><name><surname>Chapman</surname><given-names>ER</given-names></name><name><surname>Gerona</surname><given-names>RRL</given-names></name><name><surname>Martin</surname><given-names>TFJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Caps acts at a prefusion step in dense-core vesicle exocytosis as a PIP2 binding protein</article-title><source>Neuron</source><volume>43</volume><fpage>551</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2004.07.028</pub-id><pub-id pub-id-type="pmid">15312653</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grushin</surname><given-names>K</given-names></name><name><surname>Kalyana Sundaram</surname><given-names>RV</given-names></name><name><surname>Sindelar</surname><given-names>CV</given-names></name><name><surname>Rothman</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Munc13 structural transitions and oligomers that may choreograph successive stages in vesicle priming for neurotransmitter release</article-title><source>PNAS</source><volume>119</volume><elocation-id>e2121259119</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2121259119</pub-id><pub-id pub-id-type="pmid">35135883</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holderith</surname><given-names>N</given-names></name><name><surname>Aldahabi</surname><given-names>M</given-names></name><name><surname>Nusser</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Selective enrichment of munc13-2 in presynaptic active zones of hippocampal pyramidal cells that innervate mglur1α expressing interneurons</article-title><source>Frontiers in Synaptic Neuroscience</source><volume>13</volume><elocation-id>773209</elocation-id><pub-id pub-id-type="doi">10.3389/fnsyn.2021.773209</pub-id><pub-id pub-id-type="pmid">35221979</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houy</surname><given-names>S</given-names></name><name><surname>Groffen</surname><given-names>AJ</given-names></name><name><surname>Ziomkiewicz</surname><given-names>I</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name><name><surname>Pinheiro</surname><given-names>PS</given-names></name><name><surname>Sørensen</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Doc2B acts as a calcium sensor for vesicle priming requiring synaptotagmin-1, munc13-2 and snares</article-title><source>eLife</source><volume>6</volume><elocation-id>e27000</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.27000</pub-id><pub-id pub-id-type="pmid">29274147</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houy</surname><given-names>S</given-names></name><name><surname>Martins</surname><given-names>JS</given-names></name><name><surname>Mohrmann</surname><given-names>R</given-names></name><name><surname>Sørensen</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Measurements of exocytosis by capacitance recordings and calcium uncaging in mouse adrenal chromaffin cells</article-title><source>Methods in Molecular Biology</source><volume>2233</volume><fpage>233</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1007/978-1-0716-1044-2_16</pub-id><pub-id pub-id-type="pmid">33222139</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>DJ</given-names></name><name><surname>Khodthong</surname><given-names>C</given-names></name><name><surname>Kowalchyk</surname><given-names>JA</given-names></name><name><surname>Martin</surname><given-names>TFJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Phosphatidylinositol 4,5-bisphosphate regulates SNARE-dependent membrane fusion</article-title><source>The Journal of Cell Biology</source><volume>182</volume><fpage>355</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1083/jcb.200801056</pub-id><pub-id pub-id-type="pmid">18644890</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>DJ</given-names></name><name><surname>Khodthong</surname><given-names>C</given-names></name><name><surname>Kowalchyk</surname><given-names>JA</given-names></name><name><surname>Martin</surname><given-names>TFJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Phosphatidylinositol 4,5-bisphosphate regulation of SNARE function in membrane fusion mediated by CAPS</article-title><source>Advances in Enzyme Regulation</source><volume>50</volume><fpage>62</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.advenzreg.2009.10.012</pub-id><pub-id pub-id-type="pmid">19896969</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jockusch</surname><given-names>WJ</given-names></name><name><surname>Speidel</surname><given-names>D</given-names></name><name><surname>Sigler</surname><given-names>A</given-names></name><name><surname>Sørensen</surname><given-names>JB</given-names></name><name><surname>Varoqueaux</surname><given-names>F</given-names></name><name><surname>Rhee</surname><given-names>J-S</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>CAPS-1 and CAPS-2 are essential synaptic vesicle priming proteins</article-title><source>Cell</source><volume>131</volume><fpage>796</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.11.002</pub-id><pub-id pub-id-type="pmid">18022372</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junge</surname><given-names>HJ</given-names></name><name><surname>Rhee</surname><given-names>J-S</given-names></name><name><surname>Jahn</surname><given-names>O</given-names></name><name><surname>Varoqueaux</surname><given-names>F</given-names></name><name><surname>Spiess</surname><given-names>J</given-names></name><name><surname>Waxham</surname><given-names>MN</given-names></name><name><surname>Rosenmund</surname><given-names>C</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Calmodulin and munc13 form a ca2+ sensor/effector complex that controls short-term synaptic plasticity</article-title><source>Cell</source><volume>118</volume><fpage>389</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2004.06.029</pub-id><pub-id pub-id-type="pmid">15294163</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabachinski</surname><given-names>G</given-names></name><name><surname>Yamaga</surname><given-names>M</given-names></name><name><surname>Kielar-Grevstad</surname><given-names>DM</given-names></name><name><surname>Bruinsma</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>TFJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>CAPS and munc13 utilize distinct PIP2-linked mechanisms to promote vesicle exocytosis</article-title><source>Molecular Biology of the Cell</source><volume>25</volume><fpage>508</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1091/mbc.E12-11-0829</pub-id><pub-id pub-id-type="pmid">24356451</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabachinski</surname><given-names>G</given-names></name><name><surname>Kielar-Grevstad</surname><given-names>DM</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>James</surname><given-names>DJ</given-names></name><name><surname>Martin</surname><given-names>TFJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Resident CAPS on dense-core vesicles docks and primes vesicles for fusion</article-title><source>Molecular Biology of the Cell</source><volume>27</volume><fpage>654</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1091/mbc.E15-07-0509</pub-id><pub-id pub-id-type="pmid">26700319</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalyana Sundaram</surname><given-names>RV</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Shu</surname><given-names>T</given-names></name><name><surname>Coleman</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Pincet</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Rothman</surname><given-names>JE</given-names></name><name><surname>Krishnakumar</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Munc13 binds and recruits SNAP25 to chaperone SNARE complex assembly</article-title><source>FEBS Letters</source><volume>595</volume><fpage>297</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1002/1873-3468.14006</pub-id><pub-id pub-id-type="pmid">33222163</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>P</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Betz</surname><given-names>A</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Munc13-1 is required for the sustained release of insulin from pancreatic beta cells</article-title><source>Cell Metabolism</source><volume>3</volume><fpage>463</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2006.04.012</pub-id><pub-id pub-id-type="pmid">16697276</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawabe</surname><given-names>H</given-names></name><name><surname>Mitkovski</surname><given-names>M</given-names></name><name><surname>Kaeser</surname><given-names>PS</given-names></name><name><surname>Hirrlinger</surname><given-names>J</given-names></name><name><surname>Opazo</surname><given-names>F</given-names></name><name><surname>Nestvogel</surname><given-names>D</given-names></name><name><surname>Kalla</surname><given-names>S</given-names></name><name><surname>Fejtova</surname><given-names>A</given-names></name><name><surname>Verrier</surname><given-names>SE</given-names></name><name><surname>Bungers</surname><given-names>SR</given-names></name><name><surname>Cooper</surname><given-names>BH</given-names></name><name><surname>Varoqueaux</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Nehring</surname><given-names>RB</given-names></name><name><surname>Gundelfinger</surname><given-names>ED</given-names></name><name><surname>Rosenmund</surname><given-names>C</given-names></name><name><surname>Rizzoli</surname><given-names>SO</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name><name><surname>Rhee</surname><given-names>J-S</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>ELKS1 localizes the synaptic vesicle priming protein bmunc13-2 to a specific subset of active zones</article-title><source>The Journal of Cell Biology</source><volume>216</volume><fpage>1143</fpage><lpage>1161</lpage><pub-id pub-id-type="doi">10.1083/jcb.201606086</pub-id><pub-id pub-id-type="pmid">28264913</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreutzberger</surname><given-names>AJB</given-names></name><name><surname>Kiessling</surname><given-names>V</given-names></name><name><surname>Liang</surname><given-names>B</given-names></name><name><surname>Seelheim</surname><given-names>P</given-names></name><name><surname>Jakhanwal</surname><given-names>S</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name><name><surname>Castle</surname><given-names>JD</given-names></name><name><surname>Tamm</surname><given-names>LK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Reconstitution of calcium-mediated exocytosis of dense-core vesicles</article-title><source>Science Advances</source><volume>3</volume><elocation-id>e1603208</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.1603208</pub-id><pub-id pub-id-type="pmid">28776026</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreutzberger</surname><given-names>AJB</given-names></name><name><surname>Kiessling</surname><given-names>V</given-names></name><name><surname>Stroupe</surname><given-names>C</given-names></name><name><surname>Liang</surname><given-names>B</given-names></name><name><surname>Preobraschenski</surname><given-names>J</given-names></name><name><surname>Ganzella</surname><given-names>M</given-names></name><name><surname>Kreutzberger</surname><given-names>MAB</given-names></name><name><surname>Nakamoto</surname><given-names>R</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name><name><surname>Castle</surname><given-names>JD</given-names></name><name><surname>Tamm</surname><given-names>LK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>In vitro fusion of single synaptic and dense core vesicles reproduces key physiological properties</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>3904</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-11873-8</pub-id><pub-id pub-id-type="pmid">31467284</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuri</surname><given-names>BA</given-names></name><name><surname>Chan</surname><given-names>SA</given-names></name><name><surname>Smith</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>PACAP regulates immediate catecholamine release from adrenal chromaffin cells in an activity-dependent manner through a protein kinase C-dependent pathway</article-title><source>Journal of Neurochemistry</source><volume>110</volume><fpage>1214</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06206.x</pub-id><pub-id pub-id-type="pmid">19508428</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwan</surname><given-names>EP</given-names></name><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Sheu</surname><given-names>L</given-names></name><name><surname>Nolan</surname><given-names>CJ</given-names></name><name><surname>Prentki</surname><given-names>M</given-names></name><name><surname>Betz</surname><given-names>A</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Gaisano</surname><given-names>HY</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Munc13-1 deficiency reduces insulin secretion and causes abnormal glucose tolerance</article-title><source>Diabetes</source><volume>55</volume><fpage>1421</fpage><lpage>1429</lpage><pub-id pub-id-type="doi">10.2337/db05-1263</pub-id><pub-id pub-id-type="pmid">16644700</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Hall</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Kaplan</surname><given-names>JM</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A hyperactive form of unc-13 enhances ca<sup>2+</sup> sensitivity and synaptic vesicle release probability in <italic>C. elegans</italic></article-title><source>Cell Reports</source><volume>28</volume><fpage>2979</fpage><lpage>2995</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.08.018</pub-id><pub-id pub-id-type="pmid">31509756</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipstein</surname><given-names>N</given-names></name><name><surname>Schaks</surname><given-names>S</given-names></name><name><surname>Dimova</surname><given-names>K</given-names></name><name><surname>Kalkhof</surname><given-names>S</given-names></name><name><surname>Ihling</surname><given-names>C</given-names></name><name><surname>Kölbel</surname><given-names>K</given-names></name><name><surname>Ashery</surname><given-names>U</given-names></name><name><surname>Rhee</surname><given-names>J</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Sinz</surname><given-names>A</given-names></name><name><surname>Jahn</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Nonconserved Ca (2+) /calmodulin binding sites in Munc13s differentially control synaptic short-term plasticity</article-title><source>Molecular and Cellular Biology</source><volume>32</volume><fpage>4628</fpage><lpage>4641</lpage><pub-id pub-id-type="doi">10.1128/MCB.00933-12</pub-id><pub-id pub-id-type="pmid">22966208</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipstein</surname><given-names>N</given-names></name><name><surname>Sakaba</surname><given-names>T</given-names></name><name><surname>Cooper</surname><given-names>BH</given-names></name><name><surname>Lin</surname><given-names>K-H</given-names></name><name><surname>Strenzke</surname><given-names>N</given-names></name><name><surname>Ashery</surname><given-names>U</given-names></name><name><surname>Rhee</surname><given-names>J-S</given-names></name><name><surname>Taschenberger</surname><given-names>H</given-names></name><name><surname>Neher</surname><given-names>E</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Dynamic control of synaptic vesicle replenishment and short-term plasticity by ca(2+)-calmodulin-munc13-1 signaling</article-title><source>Neuron</source><volume>79</volume><fpage>82</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.05.011</pub-id><pub-id pub-id-type="pmid">23770256</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipstein</surname><given-names>N</given-names></name><name><surname>Chang</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>K-H</given-names></name><name><surname>López-Murcia</surname><given-names>FJ</given-names></name><name><surname>Neher</surname><given-names>E</given-names></name><name><surname>Taschenberger</surname><given-names>H</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Munc13-1 is a ca<sup>2+</sup>-phospholipid-dependent vesicle priming hub that shapes synaptic short-term plasticity and enables sustained neurotransmission</article-title><source>Neuron</source><volume>109</volume><fpage>3980</fpage><lpage>4000</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2021.09.054</pub-id><pub-id pub-id-type="pmid">34706220</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Schirra</surname><given-names>C</given-names></name><name><surname>Edelmann</surname><given-names>L</given-names></name><name><surname>Matti</surname><given-names>U</given-names></name><name><surname>Rhee</surname><given-names>J</given-names></name><name><surname>Hof</surname><given-names>D</given-names></name><name><surname>Bruns</surname><given-names>D</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Rieger</surname><given-names>H</given-names></name><name><surname>Stevens</surname><given-names>DR</given-names></name><name><surname>Rettig</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Two distinct secretory vesicle-priming steps in adrenal chromaffin cells</article-title><source>The Journal of Cell Biology</source><volume>190</volume><fpage>1067</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1083/jcb.201001164</pub-id><pub-id pub-id-type="pmid">20855507</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Bai</surname><given-names>H</given-names></name><name><surname>Hui</surname><given-names>E</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Evans</surname><given-names>CS</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Kwon</surname><given-names>SE</given-names></name><name><surname>Chapman</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Synaptotagmin 7 functions as a ca2+-sensor for synaptic vesicle replenishment</article-title><source>eLife</source><volume>3</volume><elocation-id>e01524</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.01524</pub-id><pub-id pub-id-type="pmid">24569478</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Seven</surname><given-names>AB</given-names></name><name><surname>Camacho</surname><given-names>M</given-names></name><name><surname>Esser</surname><given-names>V</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Trimbuch</surname><given-names>T</given-names></name><name><surname>Quade</surname><given-names>B</given-names></name><name><surname>Su</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Rosenmund</surname><given-names>C</given-names></name><name><surname>Rizo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Functional synergy between the Munc13 C-terminal C1 and C2 domains</article-title><source>eLife</source><volume>5</volume><elocation-id>e13696</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.13696</pub-id><pub-id pub-id-type="pmid">27213521</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lou</surname><given-names>X</given-names></name><name><surname>Scheuss</surname><given-names>V</given-names></name><name><surname>Schneggenburger</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Allosteric modulation of the presynaptic Ca2+ sensor for vesicle fusion</article-title><source>Nature</source><volume>435</volume><fpage>497</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1038/nature03568</pub-id><pub-id pub-id-type="pmid">15917809</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Rizo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Munc13 mediates the transition from the closed syntaxin-munc18 complex to the SNARE complex</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>18</volume><fpage>542</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1038/nsmb.2047</pub-id><pub-id pub-id-type="pmid">21499244</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malenka</surname><given-names>RC</given-names></name><name><surname>Madison</surname><given-names>DV</given-names></name><name><surname>Nicoll</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Potentiation of synaptic transmission in the hippocampus by phorbol esters</article-title><source>Nature</source><volume>321</volume><fpage>175</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1038/321175a0</pub-id><pub-id pub-id-type="pmid">3010137</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Man</surname><given-names>KNM</given-names></name><name><surname>Imig</surname><given-names>C</given-names></name><name><surname>Walter</surname><given-names>AM</given-names></name><name><surname>Pinheiro</surname><given-names>PS</given-names></name><name><surname>Stevens</surname><given-names>DR</given-names></name><name><surname>Rettig</surname><given-names>J</given-names></name><name><surname>Sørensen</surname><given-names>JB</given-names></name><name><surname>Cooper</surname><given-names>BH</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Wojcik</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Identification of a Munc13-sensitive step in chromaffin cell large dense-core vesicle exocytosis</article-title><source>eLife</source><volume>4</volume><elocation-id>e10635</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.10635</pub-id><pub-id pub-id-type="pmid">26575293</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruyama</surname><given-names>IN</given-names></name><name><surname>Brenner</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>A phorbol ester/diacylglycerol-binding protein encoded by the unc-13 gene of <italic>Caenorhabditis elegans</italic></article-title><source>PNAS</source><volume>88</volume><fpage>5729</fpage><lpage>5733</lpage><pub-id pub-id-type="doi">10.1073/pnas.88.13.5729</pub-id><pub-id pub-id-type="pmid">2062851</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maximov</surname><given-names>A</given-names></name><name><surname>Lao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Rizo</surname><given-names>J</given-names></name><name><surname>Sørensen</surname><given-names>JB</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Genetic analysis of synaptotagmin-7 function in synaptic vesicle exocytosis</article-title><source>PNAS</source><volume>105</volume><fpage>3986</fpage><lpage>3991</lpage><pub-id pub-id-type="doi">10.1073/pnas.0712372105</pub-id><pub-id pub-id-type="pmid">18308933</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michelassi</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Dittman</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A C1-C2 module in munc13 inhibits calcium-dependent neurotransmitter release</article-title><source>Neuron</source><volume>95</volume><fpage>577</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.07.015</pub-id><pub-id pub-id-type="pmid">28772122</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milosevic</surname><given-names>I</given-names></name><name><surname>Sørensen</surname><given-names>JB</given-names></name><name><surname>Lang</surname><given-names>T</given-names></name><name><surname>Krauss</surname><given-names>M</given-names></name><name><surname>Nagy</surname><given-names>G</given-names></name><name><surname>Haucke</surname><given-names>V</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name><name><surname>Neher</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Plasmalemmal phosphatidylinositol-4,5-bisphosphate level regulates the releasable vesicle pool size in chromaffin cells</article-title><source>The Journal of Neuroscience</source><volume>25</volume><fpage>2557</fpage><lpage>2565</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3761-04.2005</pub-id><pub-id pub-id-type="pmid">15758165</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohrmann</surname><given-names>R</given-names></name><name><surname>Dhara</surname><given-names>M</given-names></name><name><surname>Bruns</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Complexins: small but capable</article-title><source>Cellular and Molecular Life Sciences</source><volume>72</volume><fpage>4221</fpage><lpage>4235</lpage><pub-id pub-id-type="doi">10.1007/s00018-015-1998-8</pub-id><pub-id pub-id-type="pmid">26245303</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagy</surname><given-names>G</given-names></name><name><surname>Matti</surname><given-names>U</given-names></name><name><surname>Nehring</surname><given-names>RB</given-names></name><name><surname>Binz</surname><given-names>T</given-names></name><name><surname>Rettig</surname><given-names>J</given-names></name><name><surname>Neher</surname><given-names>E</given-names></name><name><surname>Sørensen</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Protein kinase C-dependent phosphorylation of synaptosome-associated protein of 25 kDa at Ser187 potentiates vesicle recruitment</article-title><source>The Journal of Neuroscience</source><volume>22</volume><fpage>9278</fpage><lpage>9286</lpage><pub-id pub-id-type="pmid">12417653</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagy</surname><given-names>G</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Pang</surname><given-names>ZP</given-names></name><name><surname>Matti</surname><given-names>U</given-names></name><name><surname>Rettig</surname><given-names>J</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name><name><surname>Sørensen</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Different effects on fast exocytosis induced by synaptotagmin 1 and 2 isoforms and abundance but not by phosphorylation</article-title><source>The Journal of Neuroscience</source><volume>26</volume><fpage>632</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2589-05.2006</pub-id><pub-id pub-id-type="pmid">16407561</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neher</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Neurosecretion: what can we learn from chromaffin cells</article-title><source>Pflugers Archiv</source><volume>470</volume><fpage>7</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1007/s00424-017-2051-6</pub-id><pub-id pub-id-type="pmid">28801866</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen Truong</surname><given-names>CQ</given-names></name><name><surname>Nestvogel</surname><given-names>D</given-names></name><name><surname>Ratai</surname><given-names>O</given-names></name><name><surname>Schirra</surname><given-names>C</given-names></name><name><surname>Stevens</surname><given-names>DR</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Rhee</surname><given-names>J</given-names></name><name><surname>Rettig</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Secretory vesicle priming by caps is independent of its SNARE-binding MUN domain</article-title><source>Cell Reports</source><volume>9</volume><fpage>902</fpage><lpage>909</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.09.050</pub-id><pub-id pub-id-type="pmid">25437547</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nili</surname><given-names>U</given-names></name><name><surname>de Wit</surname><given-names>H</given-names></name><name><surname>Gulyas-Kovacs</surname><given-names>A</given-names></name><name><surname>Toonen</surname><given-names>RF</given-names></name><name><surname>Sørensen</surname><given-names>JB</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name><name><surname>Ashery</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Munc18-1 phosphorylation by protein kinase C potentiates vesicle pool replenishment in bovine chromaffin cells</article-title><source>Neuroscience</source><volume>143</volume><fpage>487</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2006.08.014</pub-id><pub-id pub-id-type="pmid">16997485</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orita</surname><given-names>S</given-names></name><name><surname>Naito</surname><given-names>A</given-names></name><name><surname>Sakaguchi</surname><given-names>G</given-names></name><name><surname>Maeda</surname><given-names>M</given-names></name><name><surname>Igarashi</surname><given-names>H</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Takai</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Physical and functional interactions of Doc2 and Munc13 in Ca2+-dependent exocytotic machinery</article-title><source>The Journal of Biological Chemistry</source><volume>272</volume><fpage>16081</fpage><lpage>16084</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.26.16081</pub-id><pub-id pub-id-type="pmid">9195900</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padmanarayana</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Michelassi</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Betensky</surname><given-names>D</given-names></name><name><surname>Dominguez</surname><given-names>MJ</given-names></name><name><surname>Sutton</surname><given-names>RB</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Dittman</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A unique C2 domain at the C terminus of munc13 promotes synaptic vesicle priming</article-title><source>PNAS</source><volume>118</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2016276118</pub-id><pub-id pub-id-type="pmid">33836576</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parisotto</surname><given-names>D</given-names></name><name><surname>Pfau</surname><given-names>M</given-names></name><name><surname>Scheutzow</surname><given-names>A</given-names></name><name><surname>Wild</surname><given-names>K</given-names></name><name><surname>Mayer</surname><given-names>MP</given-names></name><name><surname>Malsam</surname><given-names>J</given-names></name><name><surname>Sinning</surname><given-names>I</given-names></name><name><surname>Söllner</surname><given-names>TH</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>An extended helical conformation in domain 3A of Munc18-1 provides a template for SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complex assembly</article-title><source>The Journal of Biological Chemistry</source><volume>289</volume><fpage>9639</fpage><lpage>9650</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.514273</pub-id><pub-id pub-id-type="pmid">24532794</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>YS</given-names></name><name><surname>Hur</surname><given-names>EM</given-names></name><name><surname>Choi</surname><given-names>BH</given-names></name><name><surname>Kwak</surname><given-names>E</given-names></name><name><surname>Jun</surname><given-names>DJ</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>KT</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Involvement of protein kinase C-epsilon in activity-dependent potentiation of large dense-core vesicle exocytosis in chromaffin cells</article-title><source>The Journal of Neuroscience</source><volume>26</volume><fpage>8999</fpage><lpage>9005</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2828-06.2006</pub-id><pub-id pub-id-type="pmid">16943556</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinheiro</surname><given-names>PS</given-names></name><name><surname>de Wit</surname><given-names>H</given-names></name><name><surname>Walter</surname><given-names>AM</given-names></name><name><surname>Groffen</surname><given-names>AJ</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name><name><surname>Sørensen</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Doc2B synchronizes secretion from chromaffin cells by stimulating fast and inhibiting sustained release</article-title><source>The Journal of Neuroscience</source><volume>33</volume><fpage>16459</fpage><lpage>16470</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2656-13.2013</pub-id><pub-id pub-id-type="pmid">24133251</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quade</surname><given-names>B</given-names></name><name><surname>Camacho</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Orlando</surname><given-names>M</given-names></name><name><surname>Trimbuch</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Nicastro</surname><given-names>D</given-names></name><name><surname>Rosenmund</surname><given-names>C</given-names></name><name><surname>Rizo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Membrane bridging by Munc13-1 is crucial for neurotransmitter release</article-title><source>eLife</source><volume>8</volume><elocation-id>e42806</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.42806</pub-id><pub-id pub-id-type="pmid">30816091</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname><given-names>JS</given-names></name><name><surname>Betz</surname><given-names>A</given-names></name><name><surname>Pyott</surname><given-names>S</given-names></name><name><surname>Reim</surname><given-names>K</given-names></name><name><surname>Varoqueaux</surname><given-names>F</given-names></name><name><surname>Augustin</surname><given-names>I</given-names></name><name><surname>Hesse</surname><given-names>D</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Rosenmund</surname><given-names>C</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Beta phorbol ester- and diacylglycerol-induced augmentation of transmitter release is mediated by Munc13s and not by PKCs</article-title><source>Cell</source><volume>108</volume><fpage>121</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(01)00635-3</pub-id><pub-id pub-id-type="pmid">11792326</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richmond</surname><given-names>JE</given-names></name><name><surname>Weimer</surname><given-names>RM</given-names></name><name><surname>Jorgensen</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>An open form of syntaxin bypasses the requirement for UNC-13 in vesicle priming</article-title><source>Nature</source><volume>412</volume><fpage>338</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1038/35085583</pub-id><pub-id pub-id-type="pmid">11460165</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mechanism of neurotransmitter release coming into focus</article-title><source>Protein Science</source><volume>27</volume><fpage>1364</fpage><lpage>1391</lpage><pub-id pub-id-type="doi">10.1002/pro.3445</pub-id><pub-id pub-id-type="pmid">29893445</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenmund</surname><given-names>C</given-names></name><name><surname>Sigler</surname><given-names>A</given-names></name><name><surname>Augustin</surname><given-names>I</given-names></name><name><surname>Reim</surname><given-names>K</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Rhee</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Differential control of vesicle priming and short-term plasticity by munc13 isoforms</article-title><source>Neuron</source><volume>33</volume><fpage>411</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(02)00568-8</pub-id><pub-id pub-id-type="pmid">11832228</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosmaninho-Salgado</surname><given-names>J</given-names></name><name><surname>Araújo</surname><given-names>IM</given-names></name><name><surname>Alvaro</surname><given-names>AR</given-names></name><name><surname>Duarte</surname><given-names>EP</given-names></name><name><surname>Cavadas</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Intracellular signaling mechanisms mediating catecholamine release upon activation of NPY Y1 receptors in mouse chromaffin cells</article-title><source>Journal of Neurochemistry</source><volume>103</volume><fpage>896</fpage><lpage>903</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.04899.x</pub-id><pub-id pub-id-type="pmid">17868303</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schonn</surname><given-names>J-S</given-names></name><name><surname>Maximov</surname><given-names>A</given-names></name><name><surname>Lao</surname><given-names>Y</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name><name><surname>Sørensen</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Synaptotagmin-1 and -7 are functionally overlapping ca2+ sensors for exocytosis in adrenal chromaffin cells</article-title><source>PNAS</source><volume>105</volume><fpage>3998</fpage><lpage>4003</lpage><pub-id pub-id-type="doi">10.1073/pnas.0712373105</pub-id><pub-id pub-id-type="pmid">18308932</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapira</surname><given-names>R</given-names></name><name><surname>Silberberg</surname><given-names>SD</given-names></name><name><surname>Ginsburg</surname><given-names>S</given-names></name><name><surname>Rahamimoff</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Activation of protein kinase C augments evoked transmitter release</article-title><source>Nature</source><volume>325</volume><fpage>58</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1038/325058a0</pub-id><pub-id pub-id-type="pmid">2432432</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Lindau</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Molecular mechanism of fusion pore formation driven by the neuronal SNARE complex</article-title><source>PNAS</source><volume>115</volume><fpage>12751</fpage><lpage>12756</lpage><pub-id pub-id-type="doi">10.1073/pnas.1816495115</pub-id><pub-id pub-id-type="pmid">30482862</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheu</surname><given-names>L</given-names></name><name><surname>Pasyk</surname><given-names>EA</given-names></name><name><surname>Ji</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Varoqueaux</surname><given-names>F</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Gaisano</surname><given-names>HY</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Regulation of insulin exocytosis by Munc13-1</article-title><source>The Journal of Biological Chemistry</source><volume>278</volume><fpage>27556</fpage><lpage>27563</lpage><pub-id pub-id-type="doi">10.1074/jbc.M303203200</pub-id><pub-id pub-id-type="pmid">12871971</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>T</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Rothman</surname><given-names>JE</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Munc13-1 MUN domain and munc18-1 cooperatively chaperone SNARE assembly through a tetrameric complex</article-title><source>PNAS</source><volume>117</volume><fpage>1036</fpage><lpage>1041</lpage><pub-id pub-id-type="doi">10.1073/pnas.1914361117</pub-id><pub-id pub-id-type="pmid">31888993</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sitarska</surname><given-names>E</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Quade</surname><given-names>B</given-names></name><name><surname>Stepien</surname><given-names>K</given-names></name><name><surname>Sugita</surname><given-names>K</given-names></name><name><surname>Brautigam</surname><given-names>CA</given-names></name><name><surname>Sugita</surname><given-names>S</given-names></name><name><surname>Rizo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Autoinhibition of Munc18-1 modulates synaptobrevin binding and helps to enable Munc13-dependent regulation of membrane fusion</article-title><source>eLife</source><volume>6</volume><elocation-id>e24278</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.24278</pub-id><pub-id pub-id-type="pmid">28477408</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>C</given-names></name><name><surname>Moser</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Neher</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Cytosolic Ca2+ acts by two separate pathways to modulate the supply of release-competent vesicles in chromaffin cells</article-title><source>Neuron</source><volume>20</volume><fpage>1243</fpage><lpage>1253</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80504-8</pub-id><pub-id pub-id-type="pmid">9655511</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soma</surname><given-names>S</given-names></name><name><surname>Kuwashima</surname><given-names>H</given-names></name><name><surname>Matsumura</surname><given-names>C</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Involvement of protein kinase C in the regulation of Na+/Ca2+ exchanger in bovine adrenal chromaffin cells</article-title><source>Clinical and Experimental Pharmacology &amp; Physiology</source><volume>36</volume><fpage>717</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1681.2009.05140.x</pub-id><pub-id pub-id-type="pmid">19207723</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sørensen</surname><given-names>JB</given-names></name><name><surname>Nagy</surname><given-names>G</given-names></name><name><surname>Varoqueaux</surname><given-names>F</given-names></name><name><surname>Nehring</surname><given-names>RB</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Wilson</surname><given-names>MC</given-names></name><name><surname>Neher</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Differential control of the releasable vesicle pools by SNAP-25 splice variants and SNAP-23</article-title><source>Cell</source><volume>114</volume><fpage>75</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(03)00477-x</pub-id><pub-id pub-id-type="pmid">12859899</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sørensen</surname><given-names>JB</given-names></name><name><surname>Wiederhold</surname><given-names>K</given-names></name><name><surname>Müller</surname><given-names>EM</given-names></name><name><surname>Milosevic</surname><given-names>I</given-names></name><name><surname>Nagy</surname><given-names>G</given-names></name><name><surname>de Groot</surname><given-names>BL</given-names></name><name><surname>Grubmüller</surname><given-names>H</given-names></name><name><surname>Fasshauer</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Sequential N- to C-terminal SNARE complex assembly drives priming and fusion of secretory vesicles</article-title><source>The EMBO Journal</source><volume>25</volume><fpage>955</fpage><lpage>966</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601003</pub-id><pub-id pub-id-type="pmid">16498411</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staal</surname><given-names>RGW</given-names></name><name><surname>Hananiya</surname><given-names>A</given-names></name><name><surname>Sulzer</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Pkc theta activity maintains normal quantal size in chromaffin cells</article-title><source>Journal of Neurochemistry</source><volume>105</volume><fpage>1635</fpage><lpage>1641</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05264.x</pub-id><pub-id pub-id-type="pmid">18248621</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>DR</given-names></name><name><surname>Wu</surname><given-names>Z-X</given-names></name><name><surname>Matti</surname><given-names>U</given-names></name><name><surname>Junge</surname><given-names>HJ</given-names></name><name><surname>Schirra</surname><given-names>C</given-names></name><name><surname>Becherer</surname><given-names>U</given-names></name><name><surname>Wojcik</surname><given-names>SM</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Rettig</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Identification of the minimal protein domain required for priming activity of Munc13-1</article-title><source>Current Biology</source><volume>15</volume><fpage>2243</fpage><lpage>2248</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2005.10.055</pub-id><pub-id pub-id-type="pmid">16271475</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Neurotransmitter release: the last millisecond in the life of a synaptic vesicle</article-title><source>Neuron</source><volume>80</volume><fpage>675</fpage><lpage>690</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.10.022</pub-id><pub-id pub-id-type="pmid">24183019</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tawfik</surname><given-names>B</given-names></name><name><surname>Martins</surname><given-names>JS</given-names></name><name><surname>Houy</surname><given-names>S</given-names></name><name><surname>Imig</surname><given-names>C</given-names></name><name><surname>Pinheiro</surname><given-names>PS</given-names></name><name><surname>Wojcik</surname><given-names>SM</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Cooper</surname><given-names>BH</given-names></name><name><surname>Sørensen</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Synaptotagmin-7 places dense-core vesicles at the cell membrane to promote munc13-2- and Ca2+-dependent priming</article-title><source>eLife</source><volume>10</volume><elocation-id>e64527</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.64527</pub-id><pub-id pub-id-type="pmid">33749593</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Bospoort</surname><given-names>R</given-names></name><name><surname>Farina</surname><given-names>M</given-names></name><name><surname>Schmitz</surname><given-names>SK</given-names></name><name><surname>de Jong</surname><given-names>A</given-names></name><name><surname>de Wit</surname><given-names>H</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name><name><surname>Toonen</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Munc13 controls the location and efficiency of dense-core vesicle release in neurons</article-title><source>The Journal of Cell Biology</source><volume>199</volume><fpage>883</fpage><lpage>891</lpage><pub-id pub-id-type="doi">10.1083/jcb.201208024</pub-id><pub-id pub-id-type="pmid">23229896</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varoqueaux</surname><given-names>F</given-names></name><name><surname>Sigler</surname><given-names>A</given-names></name><name><surname>Rhee</surname><given-names>JS</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Enk</surname><given-names>C</given-names></name><name><surname>Reim</surname><given-names>K</given-names></name><name><surname>Rosenmund</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Total arrest of spontaneous and evoked synaptic transmission but normal synaptogenesis in the absence of munc13-mediated vesicle priming</article-title><source>PNAS</source><volume>99</volume><fpage>9037</fpage><lpage>9042</lpage><pub-id pub-id-type="doi">10.1073/pnas.122623799</pub-id><pub-id pub-id-type="pmid">12070347</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varoqueaux</surname><given-names>F</given-names></name><name><surname>Sons</surname><given-names>MS</given-names></name><name><surname>Plomp</surname><given-names>JJ</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Aberrant morphology and residual transmitter release at the munc13-deficient mouse neuromuscular synapse</article-title><source>Molecular and Cellular Biology</source><volume>25</volume><fpage>5973</fpage><lpage>5984</lpage><pub-id pub-id-type="doi">10.1128/MCB.25.14.5973-5984.2005</pub-id><pub-id pub-id-type="pmid">15988013</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verhage</surname><given-names>M</given-names></name><name><surname>Sørensen</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SNAREopathies: diversity in mechanisms and symptoms</article-title><source>Neuron</source><volume>107</volume><fpage>22</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2020.05.036</pub-id><pub-id pub-id-type="pmid">32559416</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Qiao</surname><given-names>JD</given-names></name><name><surname>Liu</surname><given-names>XR</given-names></name><name><surname>Liu</surname><given-names>DT</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Ren</surname><given-names>RN</given-names></name><name><surname>Mei</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>YX</given-names></name><name><surname>Shi</surname><given-names>YW</given-names></name><name><surname>Jiang</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>SM</given-names></name><name><surname>He</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Bian</surname><given-names>WJ</given-names></name><name><surname>Li</surname><given-names>BM</given-names></name><name><surname>Yi</surname><given-names>YH</given-names></name><name><surname>Su</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>HK</given-names></name><name><surname>Gu</surname><given-names>WY</given-names></name><name><surname>Liao</surname><given-names>WP</given-names></name></person-group><year iso-8601-date="2021">2021a</year><article-title>UNC13B variants associated with partial epilepsy with favourable outcome</article-title><source>Brain</source><volume>144</volume><fpage>3050</fpage><lpage>3060</lpage><pub-id pub-id-type="doi">10.1093/brain/awab164</pub-id><pub-id pub-id-type="pmid">33876820</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>CC</given-names></name><name><surname>Weyrer</surname><given-names>C</given-names></name><name><surname>Fioravante</surname><given-names>D</given-names></name><name><surname>Kaeser</surname><given-names>PS</given-names></name><name><surname>Regehr</surname><given-names>WG</given-names></name></person-group><year iso-8601-date="2021">2021b</year><article-title>Presynaptic short-term plasticity persists in the absence of PKC phosphorylation of munc18-1</article-title><source>The Journal of Neuroscience</source><volume>41</volume><fpage>7329</fpage><lpage>7339</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0347-21.2021</pub-id><pub-id pub-id-type="pmid">34290081</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wierda</surname><given-names>KDB</given-names></name><name><surname>Toonen</surname><given-names>RFG</given-names></name><name><surname>de Wit</surname><given-names>H</given-names></name><name><surname>Brussaard</surname><given-names>AB</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Interdependence of PKC-dependent and PKC-independent pathways for presynaptic plasticity</article-title><source>Neuron</source><volume>54</volume><fpage>275</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2007.04.001</pub-id><pub-id pub-id-type="pmid">17442248</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Camacho</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Esser</surname><given-names>V</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Trimbuch</surname><given-names>T</given-names></name><name><surname>Rizo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mechanistic insights into neurotransmitter release and presynaptic plasticity from the crystal structure of munc13-1 C1C2BMUN</article-title><source>eLife</source><volume>6</volume><elocation-id>22567</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.22567</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Sheng</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Zou</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Kang</surname><given-names>L</given-names></name><name><surname>Rizo</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Syntaxin opening by the MUN domain underlies the function of Munc13 in synaptic-vesicle priming</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>22</volume><fpage>547</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1038/nsmb.3038</pub-id><pub-id pub-id-type="pmid">26030875</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zikich</surname><given-names>D</given-names></name><name><surname>Mezer</surname><given-names>A</given-names></name><name><surname>Varoqueaux</surname><given-names>F</given-names></name><name><surname>Sheinin</surname><given-names>A</given-names></name><name><surname>Junge</surname><given-names>HJ</given-names></name><name><surname>Nachliel</surname><given-names>E</given-names></name><name><surname>Melamed</surname><given-names>R</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Gutman</surname><given-names>M</given-names></name><name><surname>Ashery</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Vesicle priming and recruitment by ubMunc13-2 are differentially regulated by calcium and calmodulin</article-title><source>The Journal of Neuroscience</source><volume>28</volume><fpage>1949</fpage><lpage>1960</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5096-07.2008</pub-id><pub-id pub-id-type="pmid">18287511</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.79433.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Brunger</surname><given-names>Axel T</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/006w34k90</institution-id><institution>Stanford University School of Medicine, Howard Hughes Medical Institute</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.04.27.489716" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.04.27.489716"/></front-stub><body><p>This fundamental study study reveals that phorbol esters have a stimulatory effect on chromaffin cell secretion via ubMunc13-2 but an inhibitory effect via Munc13-1. These convincingly demonstrated, opposing effects of the two closely related Munc13 paralogs are surprising and, although it remains unclear how these findings relate to the mechanism of synaptic vesicle release, the study reveals important differences between the two isoforms of this central priming protein.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.79433.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Brunger</surname><given-names>Axel T</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/006w34k90</institution-id><institution>Stanford University School of Medicine, Howard Hughes Medical Institute</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.04.27.489716">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.04.27.489716v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Phorbolester-activated Munc13-1 and ubMunc13-2 exert opposing effects on dense-core vesicle secretion&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by Axel Brunger as Reviewing Editor and Suzanne Pfeffer as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1. The conserved domain architectures of Munc13-1 and ubMun13-2 are remarkably similar. Thus, the results from this study are surprising. Please comment and speculate how the different, but closely related Munc13 paralogs can have such different mechanisms.</p><p>2. It is claimed that &quot; plasma membrane targeting of Munc13-1 is inhibitory for chromaffin cell DV secretion&quot; (line 498). However, overexpression of Munc13-1 facilitates the release in wild-type cells (Figure 4-S1). Should one expect this overexpressed Munc13-1 not to increase the Ca<sup>2+</sup>-dependent membrane targeting?</p><p>3. The authors noted that in the Rosenmund et al. 2002 paper, they had shown that phorbol ester potentiated glutamate release (by more than twofold). Ideally, please perform an experiment to test whether the H567K Munc13-1 (Rhee Cell 2002), which is a phorbol ester binding deficient Munc13-1, abolishes the inhibitory effect of phorbol ester in chromaffin cells.</p><p>4. It appears that PMA itself can translocate Muncs to the plasma membrane (Figures 4 &amp;7), which might be more potent than calcium-mediated membrane targeting Figure 6 vs. 7. Several questions: The expression level of protein expression mediated by the Smiliki viruses is very difficult to control. For data shown in figure 4A, are those fluorescence aggregates inside the cell? Moreover, can the author show time-lapse images of the translocation of Muncs to membrane-mediated by PMA? Please comment.</p><p>5. To track Munc13 translocation the authors have chosen EGFP-tagged variants which overlap in the emission with the standard FuraII/Furaptra emission. Consequently, the authors omitted Ca<sup>2+</sup>-imaging in these experiments and thereby lost crucial information regarding the development of [Ca]I before and after the uncaging flash. These parameters are of central importance for the Ca<sup>2+</sup>-dependent priming and exocytosis timing, respectively. This is particularly worrisome, because in several experiments with Munc13 expression hardly any RRP component is apparent in the displayed capacitance traces, which may indicate insufficient Ca<sup>2+</sup>-dependent vesicle priming (Figure 4). Under proper calcium control, both Ashery et al. 2000 (Figure 2) and Betz et al. 2001 (Figure 6) reported that Munc13-1 overexpression in wt chromaffin cells causes at least a 300% increase in the size of the EB compared to wt cells. Performing the same experiment, but without calcium imaging, the authors in Figure 4-Sup1 show hardly any increase in the size of the EB (violet trace Figure 4-Sup1) but a rather strong increase in the sustained phase of exocytosis, a phenotype that could be a result of low intracellular pre-flash calcium levels leading to insufficient vesicle priming. Unfortunately, the authors have not chosen other red-shifted protein tag to prevent such uncertainties. Furthermore, the display of the capacitance traces in several figures does not allow the appreciation of changes in the EB size or its components (e.g. RRP). This is a limitation of this study, but we realize that it would take considerable work to repeat the experiments with a different protein tag. At the minimum, the limitations of this study should be clearly stated.</p><p>6. As central hypothesis, the authors propose that they have identified a unique stimulatory triad of ubMunc13-2, Syt7 and DAG/phorbolesters, which is needed for dense core vesicle priming and fusion. For example, in contrast to the behavior of wt cells (e.g. Figure 1A) phorbolester treatment becomes inhibitory in cells lacking Syt7 and expressing ubMunc13-2 (Figure 7). Nonetheless, previously published data by Sorensen's group, obtained under similar preflash [Ca]I conditions (Tawfik et al., 2021; Figure 6—figure supplement 2 E-H), clearly show that PMA strongly potentiates exocytosis even in the absence of Syt7. Therefore, these previous findings by Tawfik et al. clearly counter the central hypothesis of the manuscript. Please clarify these disparate results.</p><p>Essential revisions related to Statistics and Analysis:</p><p>7. The choice of statistical analyses should be reconsidered. For example, they used non-parametric Mann-Whitney tests for most of the data but did not use the student t-test. In figure 2, they used the Kruskal-Wallis test, which is a one-way ANOVA but they have genotype differences and also the effect of PMAs, two independent variables. Please justify the use of these statistical tests. (Note: a useful reference on statistical analysis is Ho et al. &quot;Moving beyond P values: data analysis with estimation graphics&quot; Nature Methods 16, 565-566, 2019).</p><p>8. Related to the previous point, some of the data appear not normally distributed, but in the text and the figures, the mean was provided. Median and box plots would be more appropriate.</p><p>9. For imaging analysis, it is unclear how the membrane portion was determined. How do the authors determine the inside intensities? How to choose the confocal images to quantify the integrated density shown in figure 1M?</p><p>10. The authors speculate about the possibility that PMA treatment PMA-treatment of Unc13b KO cells may lead to spontaneous release, depleting the cells of secretory vesicles. To test this, they determined the integrated CgA-fluorescence over the entire cell (Figure 1M, N). By analyzing submembrane CgA-fluorescence, it should be possible to focus on a potential subcellular depletion of release-ready vesicles. Please perform this analysis.</p><p>11. After showing a detailed analysis of the exocytotic burst components and their kinetics in Figure 1 and 2 the authors argue on page 9 Line 275 'Since the measurements above indicated that the main effect of PMA is on secretion amplitude, not kinetics (see also (Nagy et al., 2006)), we only distinguished between burst secretion (first 1s secretion after Ca<sup>2+</sup> uncaging, corresponding approximately to RRP and SRP fusion) and sustained secretion (last 4 s of secretion), as well as total secretion (the sum of burst and sustained release). '. However, the expression of Munc13 paralogs apparently leads to changes in the burst components and/or its kinetics (e.g. Figure 4B compare to Figure 1 or 2). In fact, these differences cannot be directly compared, because experiments like in Figure 3 and 4 lack the littermate wt control without and with PMA. Please comment.</p><p>12. Munc13 expression leads to a disproportionate increase in the sustained phase of release, which is not present with PMA. Please include detailed analyses of the exocytotic burst components and their kinetics to address these uncertainties.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.79433.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1. The conserved domain architectures of Munc13-1 and ubMun13-2 are remarkably similar. Thus, the results from this study are surprising. Please comment and speculate how the different, but closely related Munc13 paralogs can have such different mechanisms.</p></disp-quote><p>We have expanded a paragraph in the Discussion to answer this point.</p><disp-quote content-type="editor-comment"><p>2. It is claimed that &quot; plasma membrane targeting of Munc13-1 is inhibitory for chromaffin cell DV secretion&quot; (line 498). However, overexpression of Munc13-1 facilitates the release in wild-type cells (Figure 4-S1). Should one expect this overexpressed Munc13-1 not to increase the Ca<sup>2+</sup>-dependent membrane targeting?</p></disp-quote><p>We have attempted to clarify by changing the statement to “plasma membrane targeting of Munc13-1 by PMA is inhibitory.”. The context of the statement is the discussion of why Doc2B expression in Unc13b KO cells is inhibitory, which we suggest is because Doc2B will bring Munc13-1 to the plasma membrane (like PMA). Later in the Discussion, we discuss that Munc13-1 might exert its positive effect (in the absence of PMA) at the vesicular level, together with CAPS<sup>-1</sup>/2. Also note that we did not see much Ca<sup>2+</sup>dependent targeting of Munc13-1 in this investigation – at least not any that correlate with secretion.</p><disp-quote content-type="editor-comment"><p>3. The authors noted that in the Rosenmund et al. 2002 paper, they had shown that phorbol ester potentiated glutamate release (by more than twofold). Ideally, please perform an experiment to test whether the H567K Munc13-1 (Rhee Cell 2002), which is a phorbol ester binding deficient Munc13-1, abolishes the inhibitory effect of phorbol ester in chromaffin cells.</p></disp-quote><p>We have performed the experiments suggested by the reviewer, and present them in the new Figure 4 – supplementary figure 3. As expected, there is no inhibitory effect of phorbol esters in chromaffin cells expressing the H567K Munc13-1. This confirms previous data (Bauer et al., 2007) obtained in bovine chromaffin cells, which is important. We thank the reviewer for the suggestion.</p><disp-quote content-type="editor-comment"><p>4. It appears that PMA itself can translocate Muncs to the plasma membrane (Figures 4 &amp;7), which might be more potent than calcium-mediated membrane targeting Figure 6 vs. 7. Several questions: The expression level of protein expression mediated by the Smiliki viruses is very difficult to control. For data shown in figure 4A, are those fluorescence aggregates inside the cell? Moreover, can the author show time-lapse images of the translocation of Muncs to membrane-mediated by PMA? Please comment.</p></disp-quote><p>The fluorescence aggregates are found inside the cell, and are present in some cells, but not all. We do not know the reason for this, but aggregates are also visible upon expression in HEK-cells (Betz et al., 1998 and own data now shown). We have followed the suggestion by the reviewer and included time-lapse images of a few cells expressing Munc13-1, Munc13-2 and Munc13-1 H567K in the new Figure 3—figure supplement 4. The number of experiments is not large, because we can only apply PMA once to a coverslip of chromaffin cells, as PMA cannot be washed out. Nevertheless, the experiment demonstrates the recruitment of Munc131 and ubMunc13-2, but not Munc13-1 H567K to the plasma membrane, which is a nice control. Note that the actual timing of recruitment (which we imaged for 800 s) is likely dominated by the time it takes for PMA to enter the cell, and thus it is unlikely to reflect a biologically important parameter.</p><disp-quote content-type="editor-comment"><p>5. To track Munc13 translocation the authors have chosen EGFP-tagged variants which overlap in the emission with the standard FuraII/Furaptra emission. Consequently, the authors omitted Ca<sup>2+</sup>-imaging in these experiments and thereby lost crucial information regarding the development of [Ca]I before and after the uncaging flash. These parameters are of central importance for the Ca<sup>2+</sup>-dependent priming and exocytosis timing, respectively. This is particularly worrisome, because in several experiments with Munc13 expression hardly any RRP component is apparent in the displayed capacitance traces, which may indicate insufficient Ca<sup>2+</sup>-dependent vesicle priming (Figure 4). Under proper calcium control, both Ashery et al. 2000 (Figure 2) and Betz et al. 2001 (Figure 6) reported that Munc13-1 overexpression in wt chromaffin cells causes at least a 300% increase in the size of the EB compared to wt cells. Performing the same experiment, but without calcium imaging, the authors in Figure 4-Sup1 show hardly any increase in the size of the EB (violet trace Figure 4-Sup1) but a rather strong increase in the sustained phase of exocytosis, a phenotype that could be a result of low intracellular pre-flash calcium levels leading to insufficient vesicle priming. Unfortunately, the authors have not chosen other red-shifted protein tag to prevent such uncertainties. Furthermore, the display of the capacitance traces in several figures does not allow the appreciation of changes in the EB size or its components (e.g. RRP). This is a limitation of this study, but we realize that it would take considerable work to repeat the experiments with a different protein tag. At the minimum, the limitations of this study should be clearly stated.</p></disp-quote><p>We have inserted a brief discussion of the difference between our data and those of Ashery and Betz in the beginning of the Discussion. It is very hard to compare our data obtained in newborn or embryonic mouse chromaffin cells directly to experiments performed a long time ago in adult bovine chromaffin cells (Ashery et al., 2000, Betz et al., 2001). None of those two papers reported (or – based on their use of low affinity fura-dyes – could have measured) the calcium-concentration in the cell before stimulation. Calcium dependent priming has been studied in detail primarily in mouse chromaffin cells (starting with Voets, 2000, Neuron 28: 537-545), and whether it works the same way in adult bovine cells is unclear. Therefore, there is a species/age difference, which makes it hard to compare to the previous work. It is also not clear whether the stimulation paradigm is really similar, since previous experiments sometimes made use of ‘prestimulation’ before the actual stimulus, to stimulate priming. We display the result of the first stimulation that the cell experienced.</p><p>With our method, we did not measure the prestimulation calcium concentration in each cell directly, but we established the range that we are working within in separate experiments. It is possible that calcium concentrations were a little lower than we thought, mainly because of uncertainties in the calcium calibration, which is an intrinsic limitation of calcium-experiments. However, both groups were measured in parallel experiments, on the same days. We clearly state that because of this design, some experiments might fall outside the estimated range. Because the findings in our manuscript were somewhat unexpected, we chose to use the exact same constructs that had been used previously, re-sequencing them to establish their identity. There is always a trade-off involved in these decisions, and we agree with the reviewer that using a red-shifted tag would have been elegant. We think that the limitations of our study do not put our conclusions in doubt.</p><disp-quote content-type="editor-comment"><p>6. As central hypothesis, the authors propose that they have identified a unique stimulatory triad of ubMunc13-2, Syt7 and DAG/phorbolesters, which is needed for dense core vesicle priming and fusion. For example, in contrast to the behavior of wt cells (e.g. Figure 1A) phorbolester treatment becomes inhibitory in cells lacking Syt7 and expressing ubMunc13-2 (Figure 7). Nonetheless, previously published data by Sorensen's group, obtained under similar preflash [Ca]I conditions (Tawfik et al., 2021; Figure 6—figure supplement 2 E-H), clearly show that PMA strongly potentiates exocytosis even in the absence of Syt7. Therefore, these previous findings by Tawfik et al. clearly counter the central hypothesis of the manuscript. Please clarify these disparate results.</p></disp-quote><p>Thank you for pointing out that the link to our previous paper was not clearly established in our manuscript. First, it was an overstatement to use the words ‘obligatorily’ and ‘unique’ for the functional pairing between phorbolester x ubMunc13-2 and syt7, since our previous paper showed – as the reviewer correctly points out – that in the absence of syt7 other mechanisms can kick in at higher prestimulation calcium concentration. We have softened the claims and we have added explicit discussion of the previous data in the Discussion section. Regarding the reduction in secretion upon application of PMA in Syt7 KO cells overexpression ubMunc13-2, the reduction in secretion is directly related to the increase in secretion seen when ubMunc13-2 is overexpressed in the Syt-7 KO. This increase is basically eliminated when PMA is added. Thus, ubMunc13-2 per se can increase secretion when overexpressed in the Syt-7 KO, but not in the presence of PMA. We have added discussion of this as well, comparing to the previous paper. We hope that this has clarified the situation.</p><disp-quote content-type="editor-comment"><p>Essential revisions related to Statistics and Analysis:</p><p>7. The choice of statistical analyses should be reconsidered. For example, they used non-parametric Mann-Whitney tests for most of the data but did not use the student t-test. In figure 2, they used the Kruskal-Wallis test, which is a one-way ANOVA but they have genotype differences and also the effect of PMAs, two independent variables. Please justify the use of these statistical tests. (Note: a useful reference on statistical analysis is Ho et al. &quot;Moving beyond P values: data analysis with estimation graphics&quot; Nature Methods 16, 565-566, 2019).</p></disp-quote><p>We thank the reviewer for the useful reference and note that by displaying all data points, we follow a major recommendation of that paper. We have not inserted the δ-metric, because we feel this would overly burden already complex figures. Besides, it seems most meaningful for normally distributed data, and some of our data are not normally distributed. Regarding the choice of test, most of our tests are two-sample, and, indeed, there is always a question about whether to use t-test or Mann-Whitney test in this case. In the past, we (and others) have often resorted to a complex decision sequence, where we would first test whether the requirements for doing a t-test are fulfilled, otherwise we would do log-transform, and finally (if nothing else worked), we would perform Mann-Whitney test. However, this is not very satisfactory, because it means that the hypothesis tested will vary between data sets. For instance, the Burst size might be tested with a ttest in one instance, and a Mann-Whitney test in another instance. This tests different hypotheses (differences in means, or median), which is almost never discussed, but could have non-intuitive consequences. Therefore, in an attempt to simplify things we decided to use non-parametric tests (MannWhitney or Kruskal-Wallis) in all cases, which relies on a minimum set of assumptions. However, unfortunately, the complicated decision sequence was still present in our Statistics section. It has now been deleted and the correct rationale has been inserted.</p><p>It is a very good observation that the data in Figure 2 could be arranged as a two-way ANOVA, with genotype and PMA application as the two orthogonal factors. In that case, our hypothesis essentially states that there is an interaction between drug (PMA) and genotype. Performing this 2-way ANOVA separately on the RRP amplitude and the SRP amplitude showed that the interaction was indeed close to significant in both cases (P=0.0562 for RRP and P=0.0442 for SRP), indicating a likely interaction between the two factors. Note that this actually fits very well with the Kruskall-Wallis tests and post-tests already performed, which showed that the SRP for Munc13-1 KO PMA comparing to Munc13-1 WT PMA was significantly different (i.e. higher) (p=0.0437), whereas the for the RRP the difference was non-significant. The two ways of analyzing the data do not seem test exactly the same hypothesis, though, since stating that there is an interaction between two terms is weaker/different than stating that one genotype has a different response than the other in the presence of drug – and another point is that the ANOVA is parametric, but the Kruskal-Wallis is nonparametric. We have therefore opted to add the ANOVA to the analysis and text, while keeping the original analysis as well.</p><disp-quote content-type="editor-comment"><p>8. Related to the previous point, some of the data appear not normally distributed, but in the text and the figures, the mean was provided. Median and box plots would be more appropriate.</p></disp-quote><p>We appreciate the point, and we have changed the display of all graphs to be box-and-whiskers with individual data displayed, so the entire distribution is still visible. We have also updated the source data for each figure with the median value. We still cite the mean ± SEM in the text – and they are still in the source data – because these values are often used in the field. Overall, we now cite mean, SEM, median and display all data for each data set, so all relevant information is available for the reader.</p><disp-quote content-type="editor-comment"><p>9. For imaging analysis, it is unclear how the membrane portion was determined. How do the authors determine the inside intensities? How to choose the confocal images to quantify the integrated density shown in figure 1M?</p></disp-quote><p>This is the procedure as stated (now clarified) in the Materials and methods: “Integrated densities of ROIs manually drawn around the entire cell (Total intensity) or excluding the rim of the cell (Inside intensity) were background subtracted. The Total intensity divided by the Inside intensity was used as a measure for plasma membrane localization.” For confocal images, we obtained a stack of images and for quantification used the image plane, where the cell diameter was largest. This information has been added to the Materials and methods.</p><disp-quote content-type="editor-comment"><p>10. The authors speculate about the possibility that PMA treatment PMA-treatment of Unc13b KO cells may lead to spontaneous release, depleting the cells of secretory vesicles. To test this, they determined the integrated CgA-fluorescence over the entire cell (Figure 1M, N). By analyzing submembrane CgA-fluorescence, it should be possible to focus on a potential subcellular depletion of release-ready vesicles. Please perform this analysis.</p></disp-quote><p>This is a good idea, and we have performed the analysis – it is included in the new Figure 1O. There are no significant differences.</p><disp-quote content-type="editor-comment"><p>11. After showing a detailed analysis of the exocytotic burst components and their kinetics in Figure 1 and 2 the authors argue on page 9 Line 275 'Since the measurements above indicated that the main effect of PMA is on secretion amplitude, not kinetics (see also (Nagy et al., 2006)), we only distinguished between burst secretion (first 1s secretion after Ca<sup>2+</sup> uncaging, corresponding approximately to RRP and SRP fusion) and sustained secretion (last 4 s of secretion), as well as total secretion (the sum of burst and sustained release). '. However, the expression of Munc13 paralogs apparently leads to changes in the burst components and/or its kinetics (e.g. Figure 4B compare to Figure 1 or 2). In fact, these differences cannot be directly compared, because experiments like in Figure 3 and 4 lack the littermate wt control without and with PMA. Please comment.</p></disp-quote><p>It is true that there are changes in burst components after expressing Munc13 paralogs, but this is expected if the burst size is changed, which would be expected to change both bust components (RRP and SRP). It would not be visible from our plots of average capacitance changes whether time constants for fusion are changed. We decided to simplify the analysis, because Figure 1 and 2, as well as previous data, indicated that the major change by PMA is on the amplitude of secretion, whereas kinetics is not much affected. Moreover, our results (increase or decrease in overall secretion amplitude) does not require kinetic analysis. We therefore felt that presenting the full kinetic analysis of every experiment detracts attention from the main finding. We simplified the analysis to focus attention on the main findings. None of our conclusions are based on fusion kinetics. We probably do not fully understand the final comment (‘In fact… without and with PMA’). Comparison between Munc13-1-EGFP and Munc13-1-EGFP + PMA in Figure 4 clearly show a decrease by PMA, whereas experiments in wt control cells (from the same mouse line, i.e. <italic>Unc13a</italic>) in Figure 2 show an increase by PMA application. Thus, the difference is clear. We only plot experiments in the same graph (and compare them statistically) when they have been carried out in parallel experiments (i.e. using the same cultures on the same measurement days), and doing experiments in four different groups on every recording day is very cumbersome.</p><disp-quote content-type="editor-comment"><p>12. Munc13 expression leads to a disproportionate increase in the sustained phase of release, which is not present with PMA. Please include detailed analyses of the exocytotic burst components and their kinetics to address these uncertainties.</p></disp-quote><p>We are not sure what the reviewer refers to. As an example, we have now provided the full kinetic analysis of the Munc13-1 expressed in wt CD1 cells in Figure 4 —figure supplement 1. As stated above, (answer to point 11), we think that providing the full kinetic analysis in each case detracts attention from the main findings of our manuscript.</p></body></sub-article></article>